"Term","Jaccard","Odds_Ratio","Fold_Enrichment","PValue","FDR","Genes"
"GO:1903891~regulation of ATF6-mediated unfolded protein response",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"3309"
"GO:0002575~basophil chemotaxis",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"7422"
"GO:0060904~regulation of protein folding in endoplasmic reticulum",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"3309"
"GO:0072308~negative regulation of metanephric nephron tubule epithelial cell differentiation",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"6772"
"GO:0071839~apoptotic process in bone marrow cell",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"598"
"GO:1903897~regulation of PERK-mediated unfolded protein response",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"3309"
"GO:0038033~positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"7422"
"GO:0097510~base-excision repair, AP site formation via deaminated base removal",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"7374"
"GO:0043849~Ras palmitoyltransferase activity",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"51114"
"GO:0106211~inositol-5-diphosphate-1,3,4,6-tetrakisphosphate diphosphatase activity",0.0227272727272727,Inf,448.75,0.00222841225626746,0.0626674317376895,"11163"
"GO:0021589~cerebellum structural organization",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"3309"
"GO:0060668~regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"8079"
"GO:0061302~smooth muscle cell-matrix adhesion",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"780"
"GO:0046725~negative regulation by virus of viral protein levels in host cell",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"6772"
"GO:0003169~coronary vein morphogenesis",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"7422"
"GO:0097533~cellular stress response to acid chemical",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"7422"
"GO:1903141~negative regulation of establishment of endothelial barrier",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"7422"
"GO:0140744~negative regulation of lncRNA transcription",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"23211"
"GO:0003065~positive regulation of heart rate by epinephrine",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"7170"
"GO:1905344~prostaglandin catabolic process",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"11313"
"GO:2001295~malonyl-CoA biosynthetic process",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"31"
"GO:0038190~VEGF-activated neuropilin signaling pathway",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"7422"
"GO:0097048~dendritic cell apoptotic process",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"598"
"GO:0035683~memory T cell extravasation",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"50848"
"GO:0071027~nuclear RNA surveillance",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"23211"
"GO:0003340~negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"6772"
"GO:0110064~lncRNA catabolic process",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"23211"
"GO:0052848~inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"11163"
"GO:0052845~inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"11163"
"R-HSA-9632697~Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"1019"
"R-HSA-9630791~Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4",0.0222222222222222,451.792678699578,224.375,0.00445197130512909,0.065587631845631,"1019"
"GO:0060260~regulation of transcription initiation by RNA polymerase II",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"1019"
"GO:0044565~dendritic cell proliferation",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"598"
"GO:0038091~positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"7422"
"GO:0072136~metanephric mesenchymal cell proliferation involved in metanephros development",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"6772"
"GO:0036303~lymph vessel morphogenesis",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"7422"
"GO:0061326~renal tubule development",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"6772"
"GO:1901492~positive regulation of lymphangiogenesis",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"7422"
"GO:0045601~regulation of endothelial cell differentiation",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"7422"
"GO:1903392~negative regulation of adherens junction organization",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"7422"
"GO:0060948~cardiac vascular smooth muscle cell development",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"7422"
"GO:1905604~negative regulation of blood-brain barrier permeability",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"7422"
"GO:0070682~proteasome regulatory particle assembly",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"5715"
"GO:1903894~regulation of IRE1-mediated unfolded protein response",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"3309"
"GO:0052836~inositol 5-diphosphate pentakisphosphate 5-kinase activity",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"9807"
"GO:0052839~diphosphoinositol tetrakisphosphate kinase activity",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"9807"
"GO:0043183~vascular endothelial growth factor receptor 1 binding",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"7422"
"GO:0003989~acetyl-CoA carboxylase activity",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"31"
"GO:0140490~microtubule nucleator activity",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"7283"
"R-HSA-9692913~SARS-CoV-1-mediated effects on programmed cell death",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"598"
"R-HSA-9630747~Diseases of Cellular Senescence",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"1019"
"R-HSA-9630750~Evasion of Oncogene Induced Senescence Due to p16INK4A Defects",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"1019"
"R-HSA-9632693~Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"1019"
"R-HSA-9675132~Diseases of cellular response to stress",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"1019"
"R-HSA-9632700~Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"1019"
"R-HSA-9630794~Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"1019"
"R-HSA-844455~The NLRP1 inflammasome",0.0217391304347826,227.29806475758,149.583333333333,0.00667068747098909,0.065587631845631,"598"
"11.IL-6_gp130-Jak-STAT",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"6772"
"69.Survival_signaling_BH3-Bad",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"598"
"75.Stats_activators_of_Apoptosis",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"6772"
"159.14-3-3_Apoptosis",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"598"
"GO:0110088~hippocampal neuron apoptotic process",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"2002"
"GO:0046898~response to cycloheximide",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"598"
"GO:0032785~negative regulation of DNA-templated transcription, elongation",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"23211"
"GO:0031077~post-embryonic camera-type eye development",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"7422"
"GO:0032474~otolith morphogenesis",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"26018"
"GO:0010715~regulation of extracellular matrix disassembly",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"780"
"GO:0044843~cell cycle G1/S phase transition",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"4296"
"GO:0061753~substrate localization to autophagosome",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"126298"
"GO:0035437~maintenance of protein localization in endoplasmic reticulum",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"3309"
"GO:0010749~regulation of nitric oxide mediated signal transduction",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"7422"
"GO:0060319~primitive erythrocyte differentiation",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"7422"
"GO:0004945~angiotensin type II receptor activity",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"57085"
"GO:0052723~inositol hexakisphosphate 1-kinase activity",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"9807"
"GO:0004844~uracil DNA N-glycosylase activity",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"7374"
"GO:0016505~peptidase activator activity involved in apoptotic process",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"1075"
"R-HSA-1855191~Synthesis of IPs in the nucleus",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"9807"
"R-HSA-8874177~ATF6B (ATF6-beta) activates chaperones",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"3309"
"KW-0421~Lactation",0.0212765957446809,152.470606280268,112.1875,0.00888457105680973,0.0702207499359569,"780"
"R-HSA-381183~ATF6 (ATF6-alpha) activates chaperone genes",0.0392156862745098,133.311514378838,99.7222222222222,0.000172989049784972,0.0281587731038871,"3309, 4800"
"4.cyclins_&_p27_cell_cycle",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"1019"
"GO:1901907~diadenosine pentaphosphate catabolic process",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"11163"
"GO:0032946~positive regulation of mononuclear cell proliferation",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"598"
"GO:0071543~diphosphoinositol polyphosphate metabolic process",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"11163"
"GO:1904637~cellular response to ionomycin",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"1019"
"GO:0071312~cellular response to alkaloid",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"598"
"GO:1905167~positive regulation of lysosomal protein catabolic process",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"23163"
"GO:0072162~metanephric mesenchymal cell differentiation",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"6772"
"GO:0071453~cellular response to oxygen levels",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"4720"
"GO:1903052~positive regulation of proteolysis involved in protein catabolic process",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"1075"
"GO:0022405~hair cycle process",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"26018"
"GO:1901909~diadenosine hexaphosphate catabolic process",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"11163"
"GO:1901911~adenosine 5'-(hexahydrogen pentaphosphate) catabolic process",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"11163"
"GO:1905278~positive regulation of epithelial tube formation",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"7422"
"GO:0072553~terminal button organization",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"1108"
"GO:1902396~protein localization to bicellular tight junction",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"50848"
"GO:0006121~mitochondrial electron transport, succinate to ubiquinone",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"6391"
"GO:0070831~basement membrane assembly",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"8079"
"GO:0046464~acylglycerol catabolic process",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"11313"
"GO:1904714~regulation of chaperone-mediated autophagy",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"1915"
"GO:0006084~acetyl-CoA metabolic process",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"31"
"GO:1901532~regulation of hematopoietic progenitor cell differentiation",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"7422"
"GO:0048499~synaptic vesicle membrane organization",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"9144"
"GO:0008486~diphosphoinositol-polyphosphate diphosphatase activity",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"11163"
"GO:0000298~endopolyphosphatase activity",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"11163"
"GO:0000827~inositol-1,3,4,5,6-pentakisphosphate kinase activity",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"9807"
"GO:0180030~inositol phosphate kinase activity",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"9807"
"GO:0000829~diphosphoinositol pentakisphosphate kinase activity",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"9807"
"GO:0000832~inositol hexakisphosphate 5-kinase activity",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"9807"
"GO:0034431~bis(5'-adenosyl)-hexaphosphatase activity",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"11163"
"GO:0005172~vascular endothelial growth factor receptor binding",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"7422"
"GO:0019826~oxygen sensor activity",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"4720"
"GO:0036033~mediator complex binding",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"2002"
"R-HSA-1855167~Synthesis of pyrophosphates in the cytosol",0.0384615384615385,116.623752646432,89.75,0.000215929940785313,0.0316337363250483,"11163, 9807"
"R-HSA-9754119~Drug-mediated inhibition of CDK4/CDK6 activity",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"1019"
"WP5065:SARS CoV 2 altering angiogenesis via NRP1",0.0208333333333333,113.935070806998,89.75,0.0110936323441562,0.0703557202778735,"7422"
"R-HSA-381033~ATF6 (ATF6-alpha) activates chaperones",0.0377358490566038,103.71643827731,81.5909090909091,0.000263540501068494,0.0350988030968494,"3309, 4800"
"152.altered_synaptic_signalling-neurodegenerative_disorders",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"598"
"2.Cytokine_Receptors",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"6772"
"127.Mito-stress",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"598"
"GO:0036324~vascular endothelial growth factor receptor-2 signaling pathway",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"7422"
"GO:1905555~positive regulation of blood vessel branching",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"7422"
"GO:2001233~regulation of apoptotic signaling pathway",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"598"
"GO:1903895~negative regulation of IRE1-mediated unfolded protein response",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"3309"
"GO:0141111~positive regulation of cGAS/STING signaling pathway",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"51114"
"GO:0042063~gliogenesis",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"4720"
"GO:0060754~positive regulation of mast cell chemotaxis",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"7422"
"GO:1903142~positive regulation of establishment of endothelial barrier",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"50848"
"GO:0030621~U4 snRNA binding",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"7919"
"GO:0034432~bis(5'-adenosyl)-pentaphosphatase activity",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"11163"
"GO:0043008~ATP-dependent protein binding",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"7919"
"GO:0051434~BH3 domain binding",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"598"
"R-HSA-8849470~PTK6 Regulates Cell Cycle",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"1019"
"WP3943:ROBO4 and VEGF signaling crosstalk",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"7422"
"WP4317:Mitochondrial fatty acid synthesis pathway",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"31"
"WP3672:lncRNA mediated mechanisms of therapeutic resistance",0.0204081632653061,91.3253135184939,74.7916666666667,0.0132978815932371,0.0760992052112981,"598"
"94.E2F_transcriptional_activity_cell_cycle",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"1019"
"GO:1900118~negative regulation of execution phase of apoptosis",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"598"
"GO:1901165~positive regulation of trophoblast cell migration",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"7422"
"GO:0002084~protein depalmitoylation",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"11313"
"GO:0140639~positive regulation of pyroptotic inflammatory response",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"51114"
"GO:0010950~positive regulation of endopeptidase activity",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"51107"
"GO:0000212~meiotic spindle organization",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"7283"
"GO:0070072~vacuolar proton-transporting V-type ATPase complex assembly",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"9777"
"GO:0048842~positive regulation of axon extension involved in axon guidance",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"7422"
"GO:0090559~regulation of membrane permeability",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"50848"
"GO:0061469~regulation of type B pancreatic cell proliferation",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"1019"
"GO:0008186~ATP-dependent activity, acting on RNA",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"7919"
"GO:0031730~CCR5 chemokine receptor binding",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"6772"
"R-HSA-3371599~Defective HLCS causes multiple carboxylase deficiency",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"31"
"R-HSA-163765~ChREBP activates metabolic gene expression",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"31"
"WP3593:MicroRNA for targeting cancer growth and vascularization in glioblastoma",0.02,76.0698124595719,64.1071428571429,0.0154973290429509,0.0799422079152219,"7422"
"GO:0044319~wound healing, spreading of cells",0.0350877192982456,71.8724408114205,59.8333333333333,0.00050027885355952,0.0398103944017643,"780, 977"
"GO:0031204~post-translational protein targeting to membrane, translocation",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"3309"
"GO:0035148~tube formation",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"7422"
"GO:0046949~fatty-acyl-CoA biosynthetic process",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"31"
"GO:0038111~interleukin-7-mediated signaling pathway",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"6772"
"GO:0071774~response to fibroblast growth factor",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"2002"
"GO:0006474~N-terminal protein amino acid acetylation",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"80155"
"GO:0045008~depyrimidination",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"7374"
"GO:0036498~IRE1-mediated unfolded protein response",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"3309"
"GO:0038113~interleukin-9-mediated signaling pathway",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"6772"
"GO:1903980~positive regulation of microglial cell activation",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"1075"
"GO:0070106~interleukin-27-mediated signaling pathway",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"6772"
"GO:0043237~laminin-1 binding",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"8079"
"GO:0016651~oxidoreductase activity, acting on NAD(P)H",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"4720"
"GO:0000828~inositol hexakisphosphate kinase activity",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"9807"
"R-HSA-195399~VEGF binds to VEGFR leading to receptor dimerization",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"7422"
"R-HSA-9017802~Noncanonical activation of NOTCH3",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"51107"
"R-HSA-194313~VEGF ligand-receptor interactions",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"7422"
"R-HSA-450520~HuR (ELAVL1) binds and stabilizes mRNA",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"8125"
"KW-0806~Transcription termination",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"23211"
"WP4920:Mitochondrial complex II assembly",0.0196078431372549,65.247512886559,56.09375,0.0176919849109264,0.0833400575386082,"6391"
"17.Activators-CAM",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"6772"
"GO:0070863~positive regulation of protein exit from endoplasmic reticulum",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"9777"
"GO:0060346~bone trabecula formation",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"7422"
"GO:0060749~mammary gland alveolus development",0.0333333333333333,58.4531259371431,49.8611111111111,0.000725886658597888,0.046235824123735,"7422, 780"
"GO:0002070~epithelial cell maturation",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"7422"
"GO:1903589~positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"7422"
"GO:0060982~coronary artery morphogenesis",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"7422"
"GO:0014909~smooth muscle cell migration",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"780"
"GO:2000669~negative regulation of dendritic cell apoptotic process",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"598"
"GO:0031642~negative regulation of myelination",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"1075"
"GO:0007220~Notch receptor processing",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"51107"
"GO:0061042~vascular wound healing",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"7422"
"GO:2000242~negative regulation of reproductive process",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"598"
"GO:0021680~cerebellar Purkinje cell layer development",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"3309"
"GO:0035767~endothelial cell chemotaxis",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"7422"
"GO:0060426~lung vasculature development",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"7422"
"GO:0043184~vascular endothelial growth factor receptor 2 binding",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"7422"
"R-HSA-3323169~Defects in biotin (Btn) metabolism",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"31"
"R-HSA-8985947~Interleukin-9 signaling",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"6772"
"R-HSA-111453~BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"598"
"WP5031:Biotin metabolism including IMDs",0.0192307692307692,57.1227153059342,49.8611111111111,0.0198818593935695,0.0867489138661316,"31"
"83.Growth_factors_Survival_factors_Mitogens",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"1019"
"GO:0035456~response to interferon-beta",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"6772"
"GO:1902966~positive regulation of protein localization to early endosome",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"7422"
"GO:0032958~inositol phosphate biosynthetic process",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"9807"
"GO:0051093~negative regulation of developmental process",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"598"
"GO:0034205~amyloid-beta formation",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"51107"
"GO:1904628~cellular response to phorbol 13-acetate 12-myristate",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"1019"
"GO:0071394~cellular response to testosterone stimulus",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"2002"
"GO:0042775~mitochondrial ATP synthesis coupled electron transport",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"4720"
"GO:0044829~positive regulation by host of viral genome replication",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"1915"
"GO:0097475~motor neuron migration",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"7422"
"GO:0043583~ear development",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"780"
"GO:2000810~regulation of bicellular tight junction assembly",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"50848"
"GO:0008239~dipeptidyl-peptidase activity",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"1075"
"GO:0003954~NADH dehydrogenase activity",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"4720"
"R-HSA-1234158~Regulation of gene expression by Hypoxia-inducible Factor",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"7422"
"R-HSA-9702518~STAT5 activation downstream of FLT3 ITD mutants",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"598"
"R-HSA-9020958~Interleukin-21 signaling",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"6772"
"KW-0635~Pregnancy",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"780"
"WP3934:Leptin and adiponectin",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"31"
"WP2113:Type III interferon signaling",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"6772"
"WP4707:Aspirin and miRNAs",0.0188679245283019,50.7194251403581,44.875,0.0220669626661012,0.0893041444912659,"7422"
"WP4206:Hereditary leiomyomatosis and renal cell carcinoma pathway",0.032258064516129,51.9057987010347,44.875,0.000898878741889663,0.048772494698828,"31, 7422"
"48.mice_minus_JAKs_and_STATs",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"6772"
"GO:0060444~branching involved in mammary gland duct morphogenesis",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"780"
"GO:0006983~ER overload response",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"3309"
"GO:0034975~protein folding in endoplasmic reticulum",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"3309"
"GO:0090557~establishment of endothelial intestinal barrier",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"50848"
"GO:2000048~negative regulation of cell-cell adhesion mediated by cadherin",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"7422"
"GO:0016462~pyrophosphatase activity",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"11163"
"GO:0010698~acetyltransferase activator activity",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"80155"
"R-HSA-9013700~NOTCH4 Activation and Transmission of Signal to the Nucleus",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"51107"
"R-HSA-9818030~NFE2L2 regulating tumorigenic genes",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"598"
"R-HSA-446107~Type I hemidesmosome assembly",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"977"
"R-HSA-193692~Regulated proteolysis of p75NTR",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"51107"
"R-HSA-9020956~Interleukin-27 signaling",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"6772"
"R-HSA-9839383~TGFBR3 PTM regulation",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"51107"
"R-HSA-8875656~MET receptor recycling",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"23163"
"R-HSA-1059683~Interleukin-6 signaling",0.0185185185185185,45.6700092468164,40.7954545454545,0.024247304882604,0.0929903184633895,"6772"
"GO:0046902~regulation of mitochondrial membrane permeability",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"598"
"GO:0010389~regulation of G2/M transition of mitotic cell cycle",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"1019"
"GO:0042982~amyloid precursor protein metabolic process",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"51107"
"GO:1903898~negative regulation of PERK-mediated unfolded protein response",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"3309"
"GO:0038166~angiotensin-activated signaling pathway",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"57085"
"GO:0000012~single strand break repair",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"7374"
"GO:0044794~positive regulation by host of viral process",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"51114"
"GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"7422"
"GO:0006353~DNA-templated transcription termination",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"23211"
"GO:0043117~positive regulation of vascular permeability",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"7422"
"GO:0031293~membrane protein intracellular domain proteolysis",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"51107"
"GO:0048038~quinone binding",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"4720"
"GO:0140537~transcription regulator activator activity",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"2002"
"GO:0031434~mitogen-activated protein kinase kinase binding",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"4296"
"R-HSA-9673767~Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"6772"
"R-HSA-3371511~HSF1 activation",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"1915"
"R-HSA-196780~Biotin transport and metabolism",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"31"
"R-HSA-8984722~Interleukin-35 Signalling",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"6772"
"R-HSA-9673770~Signaling by PDGFRA extracellular domain mutants",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"6772"
"WP4495:IL10 anti inflammatory signaling",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"6772"
"WP1991:SRF and miRs in smooth muscle differentiation and proliferation",0.0181818181818182,41.5003256343713,37.3958333333333,0.0264228961760653,0.0946443591636569,"2002"
"GO:0071353~cellular response to interleukin-4",0.0298507462686567,40.6980449245446,35.9,0.00140927451476388,0.0626674317376895,"1019, 3309"
"73.Integrins_and_other_cell-surface_receptors",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"977"
"GO:1904753~negative regulation of vascular associated smooth muscle cell migration",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"7170"
"GO:1901731~positive regulation of platelet aggregation",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"50848"
"GO:0038083~peptidyl-tyrosine autophosphorylation",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"780"
"GO:0060333~type II interferon-mediated signaling pathway",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"6772"
"GO:0009888~tissue development",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"8079"
"GO:0016446~somatic hypermutation of immunoglobulin genes",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"7374"
"GO:0006937~regulation of muscle contraction",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"7170"
"GO:0001952~regulation of cell-matrix adhesion",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"780"
"GO:0050927~positive regulation of positive chemotaxis",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"7422"
"GO:0050892~intestinal absorption",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"50848"
"GO:0019209~kinase activator activity",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"1915"
"GO:0017070~U6 snRNA binding",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"7919"
"WP4318:Mitochondrial fission and fusion",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584177,0.0985643267166635,"598"
"R-HSA-9648002~RAS processing",0.0289855072463768,37.4177757500187,33.2407407407407,0.00164419303337811,0.0626674317376895,"51114, 598"
"GO:0071480~cellular response to gamma radiation",0.0285714285714286,35.9943546677556,32.0535714285714,0.00176816703634271,0.0626674317376895,"2002, 598"
"GO:0001946~lymphangiogenesis",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"7422"
"GO:2001028~positive regulation of endothelial cell chemotaxis",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"7422"
"GO:0071679~commissural neuron axon guidance",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"7422"
"GO:0042659~regulation of cell fate specification",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"1108"
"GO:0042987~amyloid precursor protein catabolic process",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"51107"
"GO:0097284~hepatocyte apoptotic process",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"598"
"GO:1902531~regulation of intracellular signal transduction",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"598"
"GO:0031404~chloride ion binding",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"1075"
"GO:0005161~platelet-derived growth factor receptor binding",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"7422"
"GO:0140318~protein transporter activity",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"23163"
"GO:0008474~palmitoyl-(protein) hydrolase activity",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"11313"
"R-HSA-200425~Carnitine shuttle",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"31"
"WP3969:H19 Rb E2F1 and CDK beta catenin in colorectal cancer",0.0175438596491228,35.1498366620476,32.0535714285714,0.0307598664205821,0.102184136748646,"1019"
"WP3972:PDGFR beta pathway",0.028169014084507,34.6426701517089,30.948275862069,0.00189645880605675,0.0626674317376895,"2002, 6772"
"72.IAP_interaction_with_cell_death_pathways",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"598"
"12.IL-6_type_cytok-signal-transduct",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"6772"
"26.cyclin-CDK_complexes",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"1019"
"GO:0050930~induction of positive chemotaxis",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"7422"
"GO:0016322~neuron remodeling",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"8079"
"GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"598"
"GO:0022408~negative regulation of cell-cell adhesion",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"7422"
"GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"598"
"GO:0040008~regulation of growth",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"598"
"GO:0001913~T cell mediated cytotoxicity",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"1075"
"GO:0018230~peptidyl-L-cysteine S-palmitoylation",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"51114"
"GO:0016407~acetyltransferase activity",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"80155"
"R-HSA-8866910~TFAP2 (AP-2) family regulates transcription of growth factors and their receptors",0.0172413793103448,32.6682244452845,29.9166666666667,0.032921265532512,0.105304921408581,"7422"
"GO:0030003~intracellular monoatomic cation homeostasis",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"9777"
"GO:0043647~inositol phosphate metabolic process",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"9807"
"GO:0031529~ruffle organization",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"7170"
"GO:0002687~positive regulation of leukocyte migration",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"7422"
"GO:0030049~muscle filament sliding",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"7170"
"GO:0061133~endopeptidase activator activity",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"51107"
"R-HSA-381042~PERK regulates gene expression",0.027027027027027,31.1814130656076,28.046875,0.00230705129647028,0.0626674317376895,"3309, 4800"
"R-HSA-9703648~Signaling by FLT3 ITD and TKD mutants",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"598"
"R-HSA-205043~NRIF signals cell death from the nucleus",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"51107"
"R-HSA-9614657~FOXO-mediated transcription of cell death genes",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"4800"
"WP3995:Prion disease pathway",0.027027027027027,31.1814130656076,28.046875,0.00230705129647028,0.0626674317376895,"2002, 3309"
"WP2435:Quercetin and Nf kB AP 1 induced apoptosis",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"7422"
"WP53:ID signaling",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"2002"
"WP4970:Galanin receptor pathway",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"7422"
"WP4928:MAPK pathway in congenital thyroid cancer",0.0169491525423729,30.4804671448243,28.046875,0.0350779540432355,0.108645248780846,"2002"
"67.Ikaros_and_signaling_inhibitors",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"2002"
"GO:2000573~positive regulation of DNA biosynthetic process",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"7422"
"GO:0006414~translational elongation",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"1915"
"GO:0008637~apoptotic mitochondrial changes",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"598"
"GO:0051787~misfolded protein binding",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"3309"
"GO:0140658~ATP-dependent chromatin remodeler activity",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"1108"
"GO:0031435~mitogen-activated protein kinase kinase kinase binding",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"4296"
"R-HSA-9659787~Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"1019"
"R-HSA-9661069~Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"1019"
"R-HSA-2173791~TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"50848"
"WP3853:ERK pathway in Huntington 39 s disease",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"2002"
"WP3413:NOTCH1 regulation of endothelial cell calcification",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"7422"
"WP3678:Amplification and expansion of oncogenic pathways as metastatic traits",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"7422"
"WP22:IL9 signaling",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"6772"
"WP5358:JAK STAT signaling in the regulation of beta cells",0.0263157894736842,29.2348308138708,26.3970588235294,0.00260202223189741,0.065587631845631,"1019, 6772"
"WP5372:Involvement of secretase in neurodegenerative diseases",0.0166666666666667,28.5805073485562,26.3970588235294,0.0372299419808954,0.110682724522668,"6772"
"WP400:p38 MAPK signaling",0.025974025974026,28.3508234887308,25.6428571428571,0.00275582428101832,0.065587631845631,"2002, 6772"
"GO:0060384~innervation",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"26018"
"GO:0043129~surfactant homeostasis",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"7422"
"GO:0035234~ectopic germ cell programmed cell death",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"598"
"GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"7422"
"GO:0071380~cellular response to prostaglandin E stimulus",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"31"
"GO:0030224~monocyte differentiation",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"7422"
"GO:0030297~transmembrane receptor protein tyrosine kinase activator activity",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"7422"
"R-HSA-1839117~Signaling by cytosolic FGFR1 fusion mutants",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"6772"
"WP3670:Interactions between LOXL4 and oxidative stress pathway",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"780"
"WP78:TCA cycle aka Krebs or citric acid cycle ",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"6391"
"hsa00061_Fatty_acid_biosynthesis",0.0163934426229508,26.9059116591848,24.9305555555556,0.0393772393527956,0.113629828439177,"31"
"WP127:IL5 signaling",0.0253164556962025,26.7353038363341,24.2567567567568,0.00307596846419668,0.065587631845631,"2002, 6772"
"GO:1902430~negative regulation of amyloid-beta formation",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"23163"
"GO:0031954~positive regulation of protein autophosphorylation",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"7422"
"GO:0045055~regulated exocytosis",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"9144"
"GO:0006405~RNA export from nucleus",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"7919"
"GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"598"
"GO:2000811~negative regulation of anoikis",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"598"
"GO:0006515~protein quality control for misfolded or incompletely synthesized proteins",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"126298"
"GO:0004709~MAP kinase kinase kinase activity",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"4296"
"R-HSA-9670439~Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"6772"
"R-HSA-9909505~Modulation of host responses by IFN-stimulated genes",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"3309"
"R-HSA-9669938~Signaling by KIT in disease",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"6772"
"R-HSA-9854311~Maturation of TCA enzymes and regulation of TCA cycle",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"6391"
"R-HSA-8876725~Protein methylation",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"1915"
"WP3614:Photodynamic therapy induced HIF 1 survival signaling",0.025,25.9949738374749,23.6184210526316,0.00324227354344084,0.065587631845631,"598, 7422"
"WP734:Serotonin receptor 4 6 7 and NR3C signaling",0.0161290322580645,25.4176301872468,23.6184210526316,0.0415198561454385,0.115201873585355,"2002"
"hsa05212_Pancreatic_cancer",0.0341880341880342,26.8683440831136,23.3116883116883,2.57786191878976e-05,0.00827047957962596,"1019, 598, 6772, 7422"
"GO:0007595~lactation",0.0246913580246914,25.2945069644528,23.0128205128205,0.00341270934217168,0.065587631845631,"7422, 780"
"R-HSA-9013424~RHOV GTPase cycle",0.0246913580246914,25.2945069644528,23.0128205128205,0.00341270934217168,0.065587631845631,"4296, 7170"
"R-HSA-9031628~NGF-stimulated transcription",0.0246913580246914,25.2945069644528,23.0128205128205,0.00341270934217168,0.065587631845631,"1108, 2002"
"GO:0090201~negative regulation of release of cytochrome c from mitochondria",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"598"
"GO:0045807~positive regulation of endocytosis",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"977"
"GO:0042462~eye photoreceptor cell development",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"7422"
"GO:0018345~protein palmitoylation",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"51114"
"GO:0045190~isotype switching",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"7374"
"GO:0051963~regulation of synapse assembly",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"1108"
"GO:2000010~positive regulation of protein localization to cell surface",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"9777"
"GO:0004706~JUN kinase kinase kinase activity",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"4296"
"R-HSA-9671555~Signaling by PDGFR in disease",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"6772"
"WP2526:PDGF pathway",0.024390243902439,24.6206442288203,22.4375,0.00358725747913168,0.065587631845631,"2002, 6772"
"WP2828:Bladder cancer",0.024390243902439,24.6206442288203,22.4375,0.00358725747913168,0.065587631845631,"1019, 7422"
"WP205:IL7 signaling",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"6772"
"WP732:Serotonin receptor 2 and ELK SRF GATA4 signaling",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"2002"
"WP516:Hypertrophy model",0.0158730158730159,24.0685357218813,22.4375,0.0436578023245734,0.118004945397602,"7422"
"R-HSA-2426168~Activation of gene expression by SREBF (SREBP)",0.0240963855421687,23.9890115089756,21.890243902439,0.0037658996312365,0.065587631845631,"31, 4800"
"hsa05219_Bladder_cancer",0.0240963855421687,23.9890115089756,21.890243902439,0.0037658996312365,0.065587631845631,"1019, 7422"
"100.MAPK_signaling_cascades",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"4296"
"GO:2000736~regulation of stem cell differentiation",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"1108"
"GO:0031290~retinal ganglion cell axon guidance",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"7422"
"GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"7422"
"GO:0001541~ovarian follicle development",0.0238095238095238,23.3896634843173,21.3690476190476,0.00394861753341635,0.065587631845631,"598, 7422"
"GO:0009416~response to light stimulus",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"2002"
"GO:0043024~ribosomal small subunit binding",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"7374"
"GO:0016409~palmitoyltransferase activity",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"51114"
"GO:0030291~protein serine/threonine kinase inhibitor activity",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"3309"
"WP3657:Hematopoietic stem cell gene regulation by GABP alpha beta complex",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"598"
"WP5066:FOXA2 pathway",0.015625,22.8679629381979,21.3690476190476,0.0457910878352308,0.120871970592096,"31"
"GO:0008137~NADH dehydrogenase (ubiquinone) activity",0.0235294117647059,22.8200524847358,20.8720930232558,0.00413539297845796,0.065587631845631,"4697, 4720"
"WP364:IL6 signaling",0.0235294117647059,22.8200524847358,20.8720930232558,0.00413539297845796,0.065587631845631,"598, 6772"
"GO:0048593~camera-type eye morphogenesis",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"7422"
"GO:0006123~mitochondrial electron transport, cytochrome c to oxygen",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"4697"
"GO:2001243~negative regulation of intrinsic apoptotic signaling pathway",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"598"
"GO:0038191~neuropilin binding",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"7422"
"GO:0030515~snoRNA binding",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"11163"
"GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"6772"
"R-HSA-622312~Inflammasomes",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"598"
"R-HSA-9613829~Chaperone Mediated Autophagy",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"1915"
"R-HSA-198753~ERK/MAPK targets",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"2002"
"R-HSA-6807004~Negative regulation of MET activity",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"26018"
"WP4197:Immune response to tuberculosis",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"6772"
"WP357:Fatty acid biosynthesis",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"31"
"WP2817:Mammary gland development pregnancy and lactation stage 3 of 4",0.0232558139534884,22.277880763648,20.3977272727273,0.00432620781684669,0.065587631845631,"598, 7170"
"WP5342:Pathophysiological roles of DUX4 in FSHD1",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"7422"
"WP4864:Host pathogen interaction of human coronaviruses apoptosis",0.0153846153846154,21.7752357653208,20.3977272727273,0.0479197226017712,0.122946398619255,"598"
"WP4263:Pancreatic adenocarcinoma pathway",0.0310077519379845,23.0400545330491,20.1685393258427,4.56158564818165e-05,0.0111378716243102,"1019, 598, 6772, 7422"
"WP1971:Integrated cancer pathway",0.0229885057471264,21.7511304399016,19.9444444444444,0.00452104395660929,0.065587631845631,"1019, 6772"
"WP5300:TROP2 regulatory signaling",0.0229885057471264,21.7511304399016,19.9444444444444,0.00452104395660929,0.065587631845631,"1019, 6772"
"R-HSA-9013418~RHOBTB2 GTPase cycle",0.0151515151515152,20.7749556041162,19.5108695652174,0.0500437165279245,0.12618596336215,"7919"
"R-HSA-3296482~Defects in vitamin and cofactor metabolism",0.0151515151515152,20.7749556041162,19.5108695652174,0.0500437165279245,0.12618596336215,"31"
"WP4925:Unfolded protein response",0.0151515151515152,20.7749556041162,19.5108695652174,0.0500437165279245,0.12618596336215,"3309"
"WP712:Estrogen signaling",0.0151515151515152,20.7749556041162,19.5108695652174,0.0500437165279245,0.12618596336215,"2002"
"GO:0034097~response to cytokine",0.0224719101123595,20.7747322941151,19.0957446808511,0.00492270805912809,0.065587631845631,"598, 6772"
"GO:0006120~mitochondrial electron transport, NADH to ubiquinone",0.0224719101123595,20.7747322941151,19.0957446808511,0.00492270805912809,0.065587631845631,"4697, 4720"
"WP2034:Leptin signaling",0.0267857142857143,21.1028296034663,18.9612676056338,0.000530865281496426,0.0398103944017643,"2002, 31, 6772"
"GO:1904706~negative regulation of vascular associated smooth muscle cell proliferation",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"7170"
"GO:0006509~membrane protein ectodomain proteolysis",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"51107"
"GO:0051493~regulation of cytoskeleton organization",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"50848"
"GO:1903672~positive regulation of sprouting angiogenesis",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"7422"
"GO:0044389~ubiquitin-like protein ligase binding",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"6772"
"GO:0004622~lysophospholipase activity",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"11313"
"GO:0035035~histone acetyltransferase binding",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"6772"
"R-HSA-6783589~Interleukin-6 family signaling",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"6772"
"R-HSA-9012852~Signaling by NOTCH3",0.0222222222222222,20.3257946132864,18.6979166666667,0.0051295001242335,0.065587631845631,"51107, 6772"
"R-HSA-9013508~NOTCH3 Intracellular Domain Regulates Transcription",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"6772"
"R-HSA-9634638~Estrogen-dependent nuclear events downstream of ESR-membrane signaling",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"2002"
"WP1539:Angiogenesis",0.0149253731343284,19.8774865025941,18.6979166666667,0.0521630794968312,0.128868316126236,"7422"
"WP3646:Hepatitis C and hepatocellular carcinoma",0.021978021978022,19.8942085632266,18.3163265306122,0.00534024169509919,0.065587631845631,"598, 7422"
"GO:0048844~artery morphogenesis",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"7422"
"GO:0001836~release of cytochrome c from mitochondria",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"598"
"GO:0002092~positive regulation of receptor internalization",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"7422"
"GO:0032781~positive regulation of ATP-dependent activity",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"7170"
"R-HSA-9013507~NOTCH3 Activation and Transmission of Signal to the Nucleus",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"51107"
"R-HSA-9705462~Inactivation of CSF3 (G-CSF) signaling",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"6772"
"R-HSA-8854691~Interleukin-20 family signaling",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"6772"
"R-HSA-1483249~Inositol phosphate metabolism",0.0217391304347826,19.4723784305352,17.95,0.00555491496511162,0.065587631845631,"11163, 9807"
"KW-0816~Tricarboxylic acid cycle",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"6391"
"WP3872:Regulation of apoptosis by parathyroid hormone related protein",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"598"
"WP3879:4 hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"4296"
"WP395:IL4 signaling",0.0217391304347826,19.4723784305352,17.95,0.00555491496511162,0.065587631845631,"2002, 6772"
"WP1981:Thyroxine thyroid hormone production",0.0147058823529412,19.060088148467,17.95,0.0542778213710835,0.130709414033877,"2002"
"GO:0051603~proteolysis involved in protein catabolic process",0.021505376344086,19.0895420347119,17.5980392156863,0.00577350218426257,0.065587631845631,"1075, 3309"
"WP3611:Photodynamic therapy induced AP 1 survival signaling",0.021505376344086,19.0895420347119,17.5980392156863,0.00577350218426257,0.065587631845631,"2002, 598"
"GO:0007020~microtubule nucleation",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"7283"
"GO:0001894~tissue homeostasis",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"31"
"GO:0002042~cell migration involved in sprouting angiogenesis",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"7422"
"GO:0061351~neural precursor cell proliferation",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"4720"
"GO:0055010~ventricular cardiac muscle tissue morphogenesis",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"7170"
"GO:1903077~negative regulation of protein localization to plasma membrane",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"598"
"GO:0042026~protein refolding",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"3309"
"GO:0006622~protein targeting to lysosome",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"23163"
"GO:0043507~positive regulation of JUN kinase activity",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"4296"
"GO:0034341~response to type II interferon",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"6772"
"GO:0071542~dopaminergic neuron differentiation",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"7422"
"GO:0055013~cardiac muscle cell development",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"7422"
"GO:0002053~positive regulation of mesenchymal cell proliferation",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"6772"
"GO:0015267~channel activity",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"598"
"GO:0019706~protein-cysteine S-palmitoyltransferase activity",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"51114"
"R-HSA-982772~Growth hormone receptor signaling",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"6772"
"R-HSA-912694~Regulation of IFNA/IFNB signaling",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"6772"
"R-HSA-6803529~FGFR2 alternative splicing",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"3185"
"R-HSA-2979096~NOTCH2 Activation and Transmission of Signal to the Nucleus",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"51107"
"WP5284:Cell interactions of the pancreatic cancer microenvironment",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"7422"
"WP5216:Warburg effect modulated by deubiquitinating enzymes and their substrates",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"7422"
"WP5385:Growth factors and hormones in beta cell proliferation",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"1019"
"WP581:EPO receptor signaling",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"6772"
"WP5500:Bempedoic acid therapy in atherosclerosis and metabolic syndrome",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"31"
"WP2878:PPAR alpha pathway",0.0144927536231884,18.2900421670956,17.2596153846154,0.0563879519927716,0.130709414033877,"1019"
"hsa05140_Leishmaniasis",0.0252100840336134,19.1343910791001,17.2596153846154,0.000698973825912833,0.046235824123735,"1915, 2002, 6772"
"GO:0032727~positive regulation of interferon-alpha production",0.0142857142857143,17.5846151617265,16.6203703703704,0.0584934811835168,0.133285832994577,"6772"
"GO:0097696~cell surface receptor signaling pathway via STAT",0.0142857142857143,17.5846151617265,16.6203703703704,0.0584934811835168,0.133285832994577,"6772"
"GO:0072657~protein localization to membrane",0.0142857142857143,17.5846151617265,16.6203703703704,0.0584934811835168,0.133285832994577,"9777"
"GO:0051894~positive regulation of focal adhesion assembly",0.0142857142857143,17.5846151617265,16.6203703703704,0.0584934811835168,0.133285832994577,"7422"
"R-HSA-380994~ATF4 activates genes in response to endoplasmic reticulum  stress",0.0142857142857143,17.5846151617265,16.6203703703704,0.0584934811835168,0.133285832994577,"4800"
"R-HSA-1655829~Regulation of cholesterol biosynthesis by SREBP (SREBF)",0.0208333333333333,17.97973573054,16.6203703703704,0.00645257088229863,0.065587631845631,"31, 4800"
"WP3613:Photodynamic therapy induced unfolded protein response",0.0142857142857143,17.5846151617265,16.6203703703704,0.0584934811835168,0.133285832994577,"3309"
"WP4767:FGFR3 signaling in chondrocyte proliferation and terminal differentiation",0.0142857142857143,17.5846151617265,16.6203703703704,0.0584934811835168,0.133285832994577,"6772"
"WP4905:1q21 1 copy number variation syndrome",0.0142857142857143,17.5846151617265,16.6203703703704,0.0584934811835168,0.133285832994577,"50848"
"GO:0035924~cellular response to vascular endothelial growth factor stimulus",0.0140845070422535,16.9248858787017,16.0267857142857,0.0605944187445232,0.136360711921239,"7422"
"GO:1900745~positive regulation of p38MAPK cascade",0.0140845070422535,16.9248858787017,16.0267857142857,0.0605944187445232,0.136360711921239,"7422"
"GO:0010971~positive regulation of G2/M transition of mitotic cell cycle",0.0140845070422535,16.9248858787017,16.0267857142857,0.0605944187445232,0.136360711921239,"1019"
"GO:0000245~spliceosomal complex assembly",0.0140845070422535,16.9248858787017,16.0267857142857,0.0605944187445232,0.136360711921239,"7919"
"R-HSA-9682385~FLT3 signaling in disease",0.0140845070422535,16.9248858787017,16.0267857142857,0.0605944187445232,0.136360711921239,"598"
"KW-0251~Elongation factor",0.0140845070422535,16.9248858787017,16.0267857142857,0.0605944187445232,0.136360711921239,"1915"
"WP2374:Oncostatin M signaling",0.0204081632653061,17.3121460415347,16.0267857142857,0.00692453020972394,0.0673643900422888,"6772, 7422"
"WP5422:IL19 signaling",0.0140845070422535,16.9248858787017,16.0267857142857,0.0605944187445232,0.136360711921239,"6772"
"WP5121:Sphingolipid metabolism in senescence",0.0140845070422535,16.9248858787017,16.0267857142857,0.0605944187445232,0.136360711921239,"1019"
"WP4659:Gastrin signaling",0.0258064516129032,17.6346605089922,15.6086956521739,0.000123838195681367,0.0259175652390289,"2002, 4296, 598, 7422"
"GO:0051497~negative regulation of stress fiber assembly",0.0138888888888889,16.3254443241149,15.4741379310345,0.0626907744566112,0.138752116356119,"50848"
"GO:0035025~positive regulation of Rho protein signal transduction",0.0138888888888889,16.3254443241149,15.4741379310345,0.0626907744566112,0.138752116356119,"50848"
"GO:0051453~regulation of intracellular pH",0.0138888888888889,16.3254443241149,15.4741379310345,0.0626907744566112,0.138752116356119,"9777"
"GO:0004693~cyclin-dependent protein serine/threonine kinase activity",0.0138888888888889,16.3254443241149,15.4741379310345,0.0626907744566112,0.138752116356119,"1019"
"R-HSA-447115~Interleukin-12 family signaling",0.02,16.6925860210453,15.4741379310345,0.00741172410934731,0.0702207499359569,"3185, 6772"
"R-HSA-9860927~Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.0138888888888889,16.3254443241149,15.4741379310345,0.0626907744566112,0.138752116356119,"6772"
"R-HSA-186763~Downstream signal transduction",0.0138888888888889,16.3254443241149,15.4741379310345,0.0626907744566112,0.138752116356119,"6772"
"WP3965:Lipid metabolism pathway",0.0138888888888889,16.3254443241149,15.4741379310345,0.0626907744566112,0.138752116356119,"31"
"WP2032:Thyroid stimulating hormone TSH signaling",0.02,16.6925860210453,15.4741379310345,0.00741172410934731,0.0702207499359569,"1019, 6772"
"GO:0038084~vascular endothelial growth factor signaling pathway",0.0196078431372549,16.1157972334002,14.9583333333333,0.00791401393774156,0.0702207499359569,"7422, 780"
"GO:0045785~positive regulation of cell adhesion",0.0196078431372549,16.1157972334002,14.9583333333333,0.00791401393774156,0.0702207499359569,"7170, 7422"
"GO:0031032~actomyosin structure organization",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"50848"
"GO:0035458~cellular response to interferon-beta",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"6772"
"GO:0001656~metanephros development",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"51107"
"GO:0007498~mesoderm development",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"7422"
"GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"598"
"GO:1902894~negative regulation of miRNA transcription",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"7422"
"GO:0006997~nucleus organization",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"51280"
"GO:0006893~Golgi to plasma membrane transport",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"23163"
"GO:0001569~branching involved in blood vessel morphogenesis",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"7422"
"GO:1990138~neuron projection extension",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"780"
"GO:0003746~translation elongation factor activity",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"1915"
"GO:0001968~fibronectin binding",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"7422"
"GO:0009055~electron transfer activity",0.0196078431372549,16.1157972334002,14.9583333333333,0.00791401393774156,0.0702207499359569,"4720, 6391"
"GO:0051721~protein phosphatase 2A binding",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"6772"
"GO:0043425~bHLH transcription factor binding",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"5715"
"R-HSA-9674555~Signaling by CSF3 (G-CSF)",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"6772"
"R-HSA-983170~Antigen Presentation: Folding, assembly and peptide loading of class I MHC",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"3309"
"R-HSA-420029~Tight junction interactions",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"50848"
"WP4941:GPR143 in melanocytes and retinal pigment epithelium cells",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"7422"
"WP623:Oxidative phosphorylation",0.0196078431372549,16.1157972334002,14.9583333333333,0.00791401393774156,0.0702207499359569,"4697, 4720"
"hsa00020_Citrate_cycle_(TCA_cycle)",0.0136986301369863,15.7643022698168,14.9583333333333,0.0647825580802631,0.138752116356119,"6391"
"R-HSA-198725~Nuclear Events (kinase and transcription factor activation)",0.0194174757281553,15.8420876404046,14.7131147540984,0.008170776740909,0.0702207499359569,"1108, 2002"
"GO:0001935~endothelial cell proliferation",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"7422"
"GO:0008015~blood circulation",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"6772"
"GO:0034394~protein localization to cell surface",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"23163"
"GO:0048010~vascular endothelial growth factor receptor signaling pathway",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"7422"
"GO:0051085~chaperone cofactor-dependent protein refolding",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"3309"
"GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"1019"
"GO:0140662~ATP-dependent protein folding chaperone",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"3309"
"GO:0050840~extracellular matrix binding",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"7422"
"R-HSA-1839124~FGFR1 mutant receptor activation",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"6772"
"R-HSA-9843743~Transcriptional regulation of brown and beige adipocyte differentiation",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"1108"
"R-HSA-6804758~Regulation of TP53 Activity through Acetylation",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"1108"
"R-HSA-9844594~Transcriptional regulation of brown and beige adipocyte differentiation by EBF2",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"1108"
"R-HSA-450282~MAPK targets/ Nuclear events mediated by MAP kinases",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"2002"
"R-HSA-2122948~Activated NOTCH1 Transmits Signal to the Nucleus",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"51107"
"R-HSA-9680350~Signaling by CSF1 (M-CSF) in myeloid cells",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"6772"
"WP4204:Tumor suppressor activity of SMARCB1",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"1019"
"WP5180:DYRK1A involvement regarding cell proliferation in brain development",0.0192307692307692,15.5775533670239,14.4758064516129,0.00843126193511811,0.0702207499359569,"1019, 51107"
"WP4752:Base excision repair",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"7374"
"WP4912:SARS coronavirus and innate immunity",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"6772"
"hsa03060_Protein_export",0.0135135135135135,15.2386667940762,14.4758064516129,0.0668697793556604,0.138956350008571,"3309"
"WP4808:Endochondral ossification with skeletal dysplasias",0.019047619047619,15.3217645753713,14.2460317460317,0.00869545243767093,0.0702207499359569,"6772, 7422"
"WP474:Endochondral ossification",0.019047619047619,15.3217645753713,14.2460317460317,0.00869545243767093,0.0702207499359569,"6772, 7422"
"GO:0001937~negative regulation of endothelial cell proliferation",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"6772"
"GO:0007159~leukocyte cell-cell adhesion",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"50848"
"GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"598"
"GO:0051881~regulation of mitochondrial membrane potential",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"598"
"GO:0042776~proton motive force-driven mitochondrial ATP synthesis",0.0188679245283019,15.0743140116607,14.0234375,0.00896333122049416,0.0702207499359569,"4720, 6391"
"GO:0045648~positive regulation of erythrocyte differentiation",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"6772"
"GO:0005164~tumor necrosis factor receptor binding",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"6772"
"GO:0004714~transmembrane receptor protein tyrosine kinase activity",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"780"
"R-HSA-1251985~Nuclear signaling by ERBB4",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"51107"
"WP4868:Type I interferon induction and signaling during SARS CoV 2 infection",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"6772"
"hsa00640_Propanoate_metabolism",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"31"
"hsa04215_Apoptosis",0.0133333333333333,14.7472759161752,14.0234375,0.0689524480027311,0.140886103659695,"598"
"GO:0043001~Golgi to plasma membrane protein transport",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211856,0.143333044767957,"23163"
"R-HSA-71403~Citric acid cycle (TCA cycle)",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211856,0.143333044767957,"6391"
"R-HSA-2559585~Oncogene Induced Senescence",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211856,0.143333044767957,"1019"
"R-HSA-5694530~Cargo concentration in the ER",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211856,0.143333044767957,"1075"
"KW-0679~Respiratory chain",0.0185185185185185,14.6028958992232,13.5984848484848,0.00951008578688372,0.0703557202778735,"4697, 4720"
"WP422:MAPK cascade",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211856,0.143333044767957,"2002"
"WP5088:Prostaglandin signaling",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211856,0.143333044767957,"7422"
"WP4880:Host pathogen interaction of human coronaviruses interferon induction",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211856,0.143333044767957,"6772"
"WP465:Tryptophan metabolism",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211856,0.143333044767957,"6772"
"hsa04933_AGE-RAGE_signaling_pathway_in_diabetic_complications",0.0211267605633803,14.6291183521229,13.3292079207921,0.00147752958866011,0.0626674317376895,"1019, 6772, 7422"
"GO:0002230~positive regulation of defense response to virus by host",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"6772"
"GO:2001235~positive regulation of apoptotic signaling pathway",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"1075"
"GO:0006099~tricarboxylic acid cycle",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"6391"
"GO:0048469~cell maturation",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"7422"
"GO:0035633~maintenance of blood-brain barrier",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"50848"
"GO:0030332~cyclin binding",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"1019"
"KW-0095~Blood group antigen",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"977"
"WP313:Hepatocyte growth factor receptor signaling",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"2002"
"WP4241:Type 2 papillary renal cell carcinoma",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"7422"
"WP5202:Alstrom syndrome",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"7283"
"WP4685:Melanoma",0.0181818181818182,14.1604126203244,13.1985294117647,0.0100713904965127,0.0703557202778735,"1019, 2002"
"WP4922:Mitochondrial complex IV assembly",0.012987012987013,13.8549827625535,13.1985294117647,0.0731041661905577,0.144531178770806,"4697"
"GO:0009060~aerobic respiration",0.018018018018018,13.9491936329913,13.0072463768116,0.0103574571609904,0.0703557202778735,"4720, 6391"
"WP1982:Sterol regulatory element binding proteins SREBP signaling",0.018018018018018,13.9491936329913,13.0072463768116,0.0103574571609904,0.0703557202778735,"31, 4800"
"GO:0002040~sprouting angiogenesis",0.0128205128205128,13.4486671036087,12.8214285714286,0.0751732350702499,0.146838385837221,"7422"
"GO:0030225~macrophage differentiation",0.0128205128205128,13.4486671036087,12.8214285714286,0.0751732350702499,0.146838385837221,"7422"
"GO:0008016~regulation of heart contraction",0.0128205128205128,13.4486671036087,12.8214285714286,0.0751732350702499,0.146838385837221,"7170"
"GO:0046676~negative regulation of insulin secretion",0.0128205128205128,13.4486671036087,12.8214285714286,0.0751732350702499,0.146838385837221,"5715"
"GO:0000070~mitotic sister chromatid segregation",0.0128205128205128,13.4486671036087,12.8214285714286,0.0751732350702499,0.146838385837221,"7283"
"R-HSA-9706574~RHOBTB GTPase Cycle",0.0128205128205128,13.4486671036087,12.8214285714286,0.0751732350702499,0.146838385837221,"7919"
"WP3617:Photodynamic therapy induced NF kB survival signaling",0.0128205128205128,13.4486671036087,12.8214285714286,0.0751732350702499,0.146838385837221,"7422"
"WP111:Electron transport chain OXPHOS system in mitochondria",0.0205479452054795,14.0546309561631,12.8214285714286,0.00165176933089828,0.0626674317376895,"4697, 4720, 6391"
"WP2359:Parkin ubiquitin proteasomal system pathway",0.0176991150442478,13.5452869717336,12.6408450704225,0.010940335591842,0.0703557202778735,"3309, 5715"
"GO:0007017~microtubule-based process",0.0126582278481013,13.0553225673748,12.4652777777778,0.0772377899995704,0.148690357883536,"4296"
"GO:0048873~homeostasis of number of cells within a tissue",0.0126582278481013,13.0553225673748,12.4652777777778,0.0772377899995704,0.148690357883536,"7422"
"GO:0006284~base-excision repair",0.0126582278481013,13.0553225673748,12.4652777777778,0.0772377899995704,0.148690357883536,"7374"
"GO:0051287~NAD binding",0.0126582278481013,13.0553225673748,12.4652777777778,0.0772377899995704,0.148690357883536,"4720"
"GO:1990841~promoter-specific chromatin binding",0.0175438596491228,13.352040666013,12.4652777777778,0.0112371141119087,0.0709585007497681,"23211, 6772"
"R-HSA-5673000~RAF activation",0.0126582278481013,13.0553225673748,12.4652777777778,0.0772377899995704,0.148690357883536,"4296"
"R-HSA-9687139~Aberrant regulation of mitotic cell cycle due to RB1 defects",0.0126582278481013,13.0553225673748,12.4652777777778,0.0772377899995704,0.148690357883536,"1019"
"R-HSA-390522~Striated Muscle Contraction",0.0126582278481013,13.0553225673748,12.4652777777778,0.0772377899995704,0.148690357883536,"7170"
"WP5353:Macrophage stimulating protein MSP signaling",0.0201342281879195,13.6526893643601,12.4652777777778,0.00179054756270092,0.0626674317376895,"2002, 31, 7422"
"WP4877:Host pathogen interaction of human coronaviruses MAPK signaling",0.0126582278481013,13.0553225673748,12.4652777777778,0.0772377899995704,0.148690357883536,"4296"
"R-HSA-6785807~Interleukin-4 and Interleukin-13 signaling",0.02,13.5237811149574,12.3509174311927,0.00183837553098655,0.0626674317376895,"598, 6772, 7422"
"KW-0249~Electron transport",0.02,13.5237811149574,12.3509174311927,0.00183837553098655,0.0626674317376895,"4697, 4720, 6391"
"WP2263:Androgen receptor network in prostate cancer",0.02,13.5237811149574,12.3509174311927,0.00183837553098655,0.0626674317376895,"1019, 2002, 6772"
"WP4674:Head and neck squamous cell carcinoma",0.0173913043478261,13.153682999272,12.2945205479452,0.0115374300931132,0.0725422106712913,"1019, 7422"
"GO:0042542~response to hydrogen peroxide",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"6772"
"GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"598"
"GO:0002052~positive regulation of neuroblast proliferation",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"7422"
"GO:0046854~phosphatidylinositol phosphate biosynthetic process",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"9807"
"GO:0001221~transcription coregulator binding",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"1108"
"GO:0140416~transcription regulator inhibitor activity",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"2002"
"R-HSA-75105~Fatty acyl-CoA biosynthesis",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"31"
"R-HSA-1980145~Signaling by NOTCH2",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"51107"
"R-HSA-9735869~SARS-CoV-1 modulates host translation machinery",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"1915"
"WP2203:Thymic stromal lymphopoietin TSLP signaling",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"6772"
"WP2037:Prolactin signaling",0.0172413793103448,12.9714001088228,12.1283783783784,0.0118412670454555,0.0741344282974029,"2002, 6772"
"WP49:IL2 signaling",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"6772"
"WP4320:Effect of progerin on genes involved in progeria",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"1108"
"WP4558:Interferon mediated signaling",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"6772"
"WP722:Serotonin HTR1 group and FOS pathway",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"2002"
"hsa05216_Thyroid_cancer",0.0125,12.6942691018881,12.1283783783784,0.0792978405977756,0.149320483901981,"7170"
"GO:0043022~ribosome binding",0.0170940170940171,12.7940918365792,11.9666666666667,0.0121486085319334,0.0754140317766202,"3309, 80155"
"hsa04115_p53_signaling_pathway",0.0170940170940171,12.7940918365792,11.9666666666667,0.0121486085319334,0.0754140317766202,"1019, 598"
"GO:0061564~axon development",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"780"
"GO:0010719~negative regulation of epithelial to mesenchymal transition",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"7422"
"GO:0019216~regulation of lipid metabolic process",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"51280"
"GO:0031333~negative regulation of protein-containing complex assembly",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"3309"
"R-HSA-9675126~Diseases of mitotic cell cycle",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"1019"
"R-HSA-5655302~Signaling by FGFR1 in disease",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"6772"
"R-HSA-8864260~Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"7422"
"R-HSA-9694548~Maturation of spike protein",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"51114"
"WP383:Striated muscle contraction pathway",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"7170"
"WP2447:Amyotrophic lateral sclerosis ALS ",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"598"
"WP619:Type II interferon signaling",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"6772"
"WP5497:Cyclin dependent kinase 4 6 inhibitors in breast cancer",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"1019"
"hsa05340_Primary_immunodeficiency",0.0123456790123457,12.3524784986421,11.8092105263158,0.0813533964641083,0.150293475182747,"7374"
"WP4396:Nonalcoholic fatty liver disease",0.0206185567010309,13.0238413307871,11.6558441558442,0.000378974101169719,0.0364384403839562,"4296, 4697, 4720, 6391"
"hsa05220_Chronic_myeloid_leukemia",0.0168067226890756,12.4535528453793,11.6558441558442,0.0127737396234046,0.0760992052112981,"1019, 598"
"GO:0007281~germ cell development",0.0121951219512195,12.0269919292413,11.5064102564103,0.0834044671778434,0.152163816208643,"598"
"GO:0051591~response to cAMP",0.0121951219512195,12.0269919292413,11.5064102564103,0.0834044671778434,0.152163816208643,"6772"
"GO:0043542~endothelial cell migration",0.0121951219512195,12.0269919292413,11.5064102564103,0.0834044671778434,0.152163816208643,"7422"
"GO:0043536~positive regulation of blood vessel endothelial cell migration",0.0121951219512195,12.0269919292413,11.5064102564103,0.0834044671778434,0.152163816208643,"7422"
"R-HSA-8950505~Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation",0.0121951219512195,12.0269919292413,11.5064102564103,0.0834044671778434,0.152163816208643,"3185"
"R-HSA-75815~Ubiquitin-dependent degradation of Cyclin D",0.0121951219512195,12.0269919292413,11.5064102564103,0.0834044671778434,0.152163816208643,"1019"
"WP34:Ovarian infertility",0.0121951219512195,12.0269919292413,11.5064102564103,0.0834044671778434,0.152163816208643,"1019"
"WP5285:Immune infiltration in pancreatic cancer",0.0121951219512195,12.0269919292413,11.5064102564103,0.0834044671778434,0.152163816208643,"7422"
"hsa04932_Non-alcoholic_fatty_liver_disease",0.0204081632653061,12.8541226750805,11.5064102564103,0.000397962488835017,0.0364384403839562,"4296, 4697, 4720, 6391"
"R-HSA-6806834~Signaling by MET",0.0165289256198347,12.1294513404541,11.3607594936709,0.0134126929259473,0.0764575686245631,"23163, 26018"
"GO:0045333~cellular respiration",0.0120481927710843,11.7181981784987,11.21875,0.0854510622983239,0.154741416893751,"4697"
"GO:0032465~regulation of cytokinesis",0.0120481927710843,11.7181981784987,11.21875,0.0854510622983239,0.154741416893751,"598"
"GO:0042056~chemoattractant activity",0.0120481927710843,11.7181981784987,11.21875,0.0854510622983239,0.154741416893751,"7422"
"R-HSA-9725554~Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin",0.0120481927710843,11.7181981784987,11.21875,0.0854510622983239,0.154741416893751,"26018"
"KW-0497~Mitogen",0.0120481927710843,11.7181981784987,11.21875,0.0854510622983239,0.154741416893751,"7422"
"hsa01521_EGFR_tyrosine_kinase_inhibitor_resistance",0.0163934426229508,11.9734291893859,11.21875,0.0137373123728309,0.0777033306030785,"598, 7422"
"R-HSA-3000171~Non-integrin membrane-ECM interactions",0.016260162601626,11.8213567757929,11.0802469135802,0.0140653388366673,0.0786477915867082,"780, 8079"
"hsa04612_Antigen_processing_and_presentation",0.016260162601626,11.8213567757929,11.0802469135802,0.0140653388366673,0.0786477915867082,"3309, 4800"
"GO:0019233~sensory perception of pain",0.0119047619047619,11.4248443872272,10.9451219512195,0.0874931913650008,0.158048736559465,"8508"
"GO:0031492~nucleosomal DNA binding",0.0119047619047619,11.4248443872272,10.9451219512195,0.0874931913650008,0.158048736559465,"1108"
"GO:0030324~lung development",0.016,11.5284746867478,10.8132530120482,0.0147315485867478,0.0799422079152219,"2002, 7422"
"GO:0007405~neuroblast proliferation",0.0117647058823529,11.1457978093175,10.6845238095238,0.0895308638974784,0.160541879571366,"7422"
"R-HSA-6802957~Oncogenic MAPK signaling",0.0158730158730159,11.3873896708925,10.6845238095238,0.015069699888232,0.0799422079152219,"4296, 57085"
"R-HSA-1433557~Signaling by SCF-KIT",0.0117647058823529,11.1457978093175,10.6845238095238,0.0895308638974784,0.160541879571366,"6772"
"WP4806:EGFR tyrosine kinase inhibitor resistance",0.0158730158730159,11.3873896708925,10.6845238095238,0.015069699888232,0.0799422079152219,"598, 7422"
"WP4018:Clear cell renal cell carcinoma pathways",0.015748031496063,11.2497028756459,10.5588235294118,0.0154111942368635,0.0799422079152219,"31, 7422"
"WP4298:Acute viral myocarditis",0.015748031496063,11.2497028756459,10.5588235294118,0.0154111942368635,0.0799422079152219,"598, 6772"
"GO:0045429~positive regulation of nitric oxide biosynthetic process",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955503,0.162792950199613,"6772"
"GO:0060048~cardiac muscle contraction",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955503,0.162792950199613,"7170"
"GO:0052689~carboxylic ester hydrolase activity",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955503,0.162792950199613,"11313"
"GO:0008307~structural constituent of muscle",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955503,0.162792950199613,"7170"
"GO:0003727~single-stranded RNA binding",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955503,0.162792950199613,"3185"
"WP5198:Inflammatory bowel disease signaling",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955503,0.162792950199613,"6772"
"GO:0007566~embryo implantation",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"780"
"GO:0043434~response to peptide hormone",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"6772"
"GO:0042098~T cell proliferation",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"977"
"GO:0008234~cysteine-type peptidase activity",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"1075"
"R-HSA-451927~Interleukin-2 family signaling",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"6772"
"R-HSA-373752~Netrin-1 signaling",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"8079"
"WP2332:IL11 signaling",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"6772"
"WP1591:Heart development",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"7422"
"WP4577:Neurodegeneration with brain iron accumulation NBIA subtypes pathway",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"31"
"hsa03410_Base_excision_repair",0.0114942528735632,10.6281729253118,10.1988636363636,0.093592877339241,0.164318285994527,"7374"
"GO:0034614~cellular response to reactive oxygen species",0.0113636363636364,10.3862714963909,9.97222222222222,0.095617237188846,0.166761014859118,"7170"
"GO:0051539~4 iron, 4 sulfur cluster binding",0.0113636363636364,10.3862714963909,9.97222222222222,0.095617237188846,0.166761014859118,"4720"
"R-HSA-9700206~Signaling by ALK in cancer",0.0151515151515152,10.6096079317548,9.97222222222222,0.0171682582543876,0.0833400575386082,"6772, 7170"
"R-HSA-445355~Smooth Muscle Contraction",0.0113636363636364,10.3862714963909,9.97222222222222,0.095617237188846,0.166761014859118,"7170"
"R-HSA-3371556~Cellular response to heat stress",0.0151515151515152,10.6096079317548,9.97222222222222,0.0171682582543876,0.0833400575386082,"1915, 3309"
"R-HSA-9725370~Signaling by ALK fusions and activated point mutants",0.0151515151515152,10.6096079317548,9.97222222222222,0.0171682582543876,0.0833400575386082,"6772, 7170"
"WP268:Notch signaling",0.0113636363636364,10.3862714963909,9.97222222222222,0.095617237188846,0.166761014859118,"51107"
"WP2328:Allograft rejection",0.0151515151515152,10.6096079317548,9.97222222222222,0.0171682582543876,0.0833400575386082,"6772, 7422"
"WP4758:Nephrotic syndrome",0.0113636363636364,10.3862714963909,9.97222222222222,0.095617237188846,0.166761014859118,"977"
"hsa00190_Oxidative_phosphorylation",0.0170454545454545,10.843746873172,9.97222222222222,0.00337309153365086,0.065587631845631,"4697, 4720, 6391"
"hsa05012_Parkinson_disease",0.0194805194805195,11.6166312711754,9.97222222222222,2.82268927632285e-05,0.00827047957962596,"3309, 4697, 4720, 5715, 598, 6391"
"GO:0008360~regulation of cell shape",0.0169491525423729,10.7627614834895,9.89889705882353,0.00344385144932249,0.065587631845631,"50848, 7170, 7422"
"WP4630:Measles virus infection",0.0169491525423729,10.7627614834895,9.89889705882353,0.00344385144932249,0.065587631845631,"1019, 598, 6772"
"GO:0071364~cellular response to epidermal growth factor stimulus",0.0112359550561798,10.1545425579636,9.7554347826087,0.0976371783849724,0.168280548628217,"1915"
"GO:0045214~sarcomere organization",0.0112359550561798,10.1545425579636,9.7554347826087,0.0976371783849724,0.168280548628217,"7170"
"R-HSA-69236~G1 Phase",0.0112359550561798,10.1545425579636,9.7554347826087,0.0976371783849724,0.168280548628217,"1019"
"R-HSA-69231~Cyclin D associated events in G1",0.0112359550561798,10.1545425579636,9.7554347826087,0.0976371783849724,0.168280548628217,"1019"
"WP2586:Aryl hydrocarbon receptor pathway",0.0112359550561798,10.1545425579636,9.7554347826087,0.0976371783849724,0.168280548628217,"7422"
"WP2355:Corticotropin releasing hormone signaling",0.0149253731343284,10.3745084449892,9.7554347826087,0.017893933901436,0.0840211960436019,"2002, 31"
"WP4823:Genes controlling nephrogenesis",0.0112359550561798,10.1545425579636,9.7554347826087,0.0976371783849724,0.168280548628217,"7422"
"WP5078:T cell modulation in pancreatic cancer",0.0112359550561798,10.1545425579636,9.7554347826087,0.0976371783849724,0.168280548628217,"7422"
"WP4861:Endoplasmic reticulum stress response in coronavirus infection",0.0112359550561798,10.1545425579636,9.7554347826087,0.0976371783849724,0.168280548628217,"3309"
"hsa03050_Proteasome",0.0112359550561798,10.1545425579636,9.7554347826087,0.0976371783849724,0.168280548628217,"5715"
"hsa05162_Measles",0.0166666666666667,10.5195128996194,9.68525179856115,0.00366158165768091,0.065587631845631,"1019, 598, 6772"
"hsa05222_Small_cell_lung_cancer",0.0148148148148148,10.2547199912205,9.6505376344086,0.0182616058284787,0.0854736502834548,"1019, 598"
"GO:0031122~cytoplasmic microtubule organization",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"7283"
"GO:0003007~heart morphogenesis",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"7422"
"GO:0006913~nucleocytoplasmic transport",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"8125"
"R-HSA-6802949~Signaling by RAS mutants",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"4296"
"R-HSA-6802955~Paradoxical activation of RAF signaling by kinase inactive BRAF",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"4296"
"R-HSA-6802946~Signaling by moderate kinase activity BRAF mutants",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"4296"
"R-HSA-9649948~Signaling downstream of RAS mutants",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"4296"
"R-HSA-9839373~Signaling by TGFBR3",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"51107"
"R-HSA-9864848~Complex IV assembly",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"4697"
"R-HSA-8854214~TBC/RABGAPs",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"23163"
"WP2853:Endoderm differentiation",0.0164835164835165,10.3669718389417,9.54787234042553,0.00381131358038711,0.065587631845631,"31, 6772, 80155"
"hsa00620_Pyruvate_metabolism",0.0111111111111111,9.93051153042461,9.54787234042553,0.0996527103485777,0.169167115481653,"31"
"R-HSA-381119~Unfolded Protein Response (UPR)",0.0145985401459854,10.0345999668953,9.44736842105263,0.0190065406029551,0.0867489138661316,"3309, 4800"
"WP4658:Small cell lung cancer",0.0145985401459854,10.0345999668953,9.44736842105263,0.0190065406029551,0.0867489138661316,"1019, 598"
"GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"598"
"GO:0021762~substantia nigra development",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"3309"
"GO:0051781~positive regulation of cell division",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"7422"
"GO:0120163~negative regulation of cold-induced thermogenesis",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"9807"
"GO:0034446~substrate adhesion-dependent cell spreading",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"8079"
"GO:0061749~forked DNA-dependent helicase activity",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"1108"
"R-HSA-9020591~Interleukin-12 signaling",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"3185"
"R-HSA-73762~RNA Polymerase I Transcription Initiation",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"1108"
"WP2848:Pluripotent stem cell differentiation pathway",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"7422"
"WP5347:IL26 signaling",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"6772"
"WP4312:Rett syndrome",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"1108"
"WP5491:Transcriptional regulation of memory B cell differentiation",0.010989010989011,9.71994911319838,9.34895833333333,0.101663842481011,0.17021431912535,"598"
"GO:0036323~vascular endothelial growth factor receptor-1 signaling pathway",0.0108695652173913,9.51754063278229,9.15816326530612,0.103670584164051,0.171807020136125,"780"
"GO:0030855~epithelial cell differentiation",0.0142857142857143,9.72040807514009,9.15816326530612,0.0201476897078152,0.0875856540710662,"50848, 7422"
"GO:0060337~type I interferon-mediated signaling pathway",0.0108695652173913,9.51754063278229,9.15816326530612,0.103670584164051,0.171807020136125,"6772"
"GO:0036121~double-stranded DNA helicase activity",0.0108695652173913,9.51754063278229,9.15816326530612,0.103670584164051,0.171807020136125,"1108"
"GO:0009378~four-way junction helicase activity",0.0108695652173913,9.51754063278229,9.15816326530612,0.103670584164051,0.171807020136125,"1108"
"GO:0001223~transcription coactivator binding",0.0108695652173913,9.51754063278229,9.15816326530612,0.103670584164051,0.171807020136125,"6772"
"GO:1990518~single-stranded 3'-5' DNA helicase activity",0.0108695652173913,9.51754063278229,9.15816326530612,0.103670584164051,0.171807020136125,"1108"
"WP286:IL3 signaling",0.0108695652173913,9.51754063278229,9.15816326530612,0.103670584164051,0.171807020136125,"598"
"WP2637:Interleukin 1 IL 1 structural pathway",0.0108695652173913,9.51754063278229,9.15816326530612,0.103670584164051,0.171807020136125,"2002"
"WP5477:Molecular pathway for oxidative stress",0.0108695652173913,9.51754063278229,9.15816326530612,0.103670584164051,0.171807020136125,"598"
"GO:0045599~negative regulation of fat cell differentiation",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"7422"
"GO:0042311~vasodilation",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"7422"
"GO:0035790~platelet-derived growth factor receptor-alpha signaling pathway",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"780"
"GO:0003151~outflow tract morphogenesis",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"7422"
"GO:0001222~transcription corepressor binding",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"6772"
"GO:0016791~phosphatase activity",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"84064"
"R-HSA-3928665~EPH-ephrin mediated repulsion of cells",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"51107"
"R-HSA-9692914~SARS-CoV-1-host interactions",0.0140845070422535,9.5200394204177,8.975,0.0209241090678079,0.0893041444912659,"1915, 598"
"R-HSA-187577~SCF(Skp2)-mediated degradation of p27/p21",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"1019"
"WP2018:RANKL RANK signaling",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"6772"
"WP5373:Osteoarthritic chondrocyte hypertrophy",0.010752688172043,9.32272000621737,8.975,0.105672944759947,0.172958243136831,"7422"
"GO:0055088~lipid homeostasis",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"31"
"GO:0048146~positive regulation of fibroblast proliferation",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"1019"
"GO:0050673~epithelial cell proliferation",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"598"
"GO:0038145~macrophage colony-stimulating factor signaling pathway",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0038109~Kit signaling pathway",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0042149~cellular response to glucose starvation",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"3309"
"GO:0050918~positive chemotaxis",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"7422"
"GO:0038062~protein tyrosine kinase collagen receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0140584~chromatin extrusion motor activity",0.0154639175257732,9.53490733265663,8.79901960784314,0.00478827994557818,0.065587631845631,"1108, 3309, 7919"
"GO:0140665~ATP-dependent H3-H4 histone complex chaperone activity",0.0154639175257732,9.53490733265663,8.79901960784314,0.00478827994557818,0.065587631845631,"1108, 3309, 7919"
"GO:0140849~ATP-dependent H2AZ histone chaperone activity",0.0154639175257732,9.53490733265663,8.79901960784314,0.00478827994557818,0.065587631845631,"1108, 3309, 7919"
"GO:0005008~hepatocyte growth factor receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0005009~insulin receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0008288~boss receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0005020~stem cell factor receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0005011~macrophage colony-stimulating factor receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0005018~platelet-derived growth factor alpha-receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0036332~placental growth factor receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0060175~brain-derived neurotrophic factor receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"GO:0005004~GPI-linked ephrin receptor activity",0.0106382978723404,9.13854702163373,8.79901960784314,0.107670933611461,0.172958243136831,"780"
"WP1984:Integrated breast cancer pathway",0.0154639175257732,9.53490733265663,8.79901960784314,0.00478827994557818,0.065587631845631,"1019, 6772, 7422"
"GO:0061775~cohesin loader activity",0.0153061224489796,9.40783111925374,8.68548387096774,0.00496445106480135,0.065587631845631,"1108, 3309, 7919"
"GO:0031334~positive regulation of protein-containing complex assembly",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"7422"
"GO:0000423~mitophagy",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"8508"
"GO:0051087~protein-folding chaperone binding",0.0136986301369863,9.14706140739733,8.62980769230769,0.0225139713073363,0.0908621707031616,"1075, 3309"
"GO:0005019~platelet-derived growth factor beta-receptor activity",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"780"
"GO:0005007~fibroblast growth factor receptor activity",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"780"
"GO:0005006~epidermal growth factor receptor activity",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"780"
"R-HSA-9907900~Proteasome assembly",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"5715"
"R-HSA-381070~IRE1alpha activates chaperones",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"3309"
"KW-0275~Fatty acid biosynthesis",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"31"
"KW-0914~Notch signaling pathway",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"51107"
"WP107:Translation factors",0.0105263157894737,8.9577278343722,8.62980769230769,0.109664560041902,0.173872922577258,"1915"
"R-HSA-611105~Respiratory electron transport",0.0151515151515152,9.28432908222019,8.57484076433121,0.0051445020522457,0.065587631845631,"4697, 4720, 6391"
"GO:0051496~positive regulation of stress fiber assembly",0.0104166666666667,8.78452836493523,8.46698113207547,0.111653833355168,0.175695881702816,"7170"
"GO:0008092~cytoskeletal protein binding",0.0104166666666667,8.78452836493523,8.46698113207547,0.111653833355168,0.175695881702816,"7170"
"GO:0005010~insulin-like growth factor receptor activity",0.0104166666666667,8.78452836493523,8.46698113207547,0.111653833355168,0.175695881702816,"780"
"R-HSA-177929~Signaling by EGFR",0.0104166666666667,8.78452836493523,8.46698113207547,0.111653833355168,0.175695881702816,"26018"
"WP304:Kit receptor signaling",0.0104166666666667,8.78452836493523,8.46698113207547,0.111653833355168,0.175695881702816,"6772"
"WP2864:Apoptosis related network due to altered Notch3 in ovarian cancer",0.0104166666666667,8.78452836493523,8.46698113207547,0.111653833355168,0.175695881702816,"3309"
"WP5144:NRP1 triggered signaling in pancreatic cancer ",0.0104166666666667,8.78452836493523,8.46698113207547,0.111653833355168,0.175695881702816,"7422"
"R-HSA-8878166~Transcriptional regulation by RUNX2",0.0134228187919463,8.88386282895842,8.38785046728972,0.0237382918752739,0.0929903184633895,"1019, 6772"
"GO:0048661~positive regulation of smooth muscle cell proliferation",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"6772"
"GO:0031648~protein destabilization",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"23163"
"GO:0035791~platelet-derived growth factor receptor-beta signaling pathway",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"780"
"GO:0031547~brain-derived neurotrophic factor receptor signaling pathway",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"780"
"GO:0009566~fertilization",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"598"
"GO:0003689~DNA clamp loader activity",0.0147783251231527,8.98978965096471,8.31018518518519,0.00561176080020405,0.065587631845631,"1108, 3309, 7919"
"GO:0005021~vascular endothelial growth factor receptor activity",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"780"
"GO:0019902~phosphatase binding",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"1075"
"R-HSA-8848021~Signaling by PTK6",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"1019"
"R-HSA-9006927~Signaling by Non-Receptor Tyrosine Kinases",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"1019"
"WP560:TGF beta receptor signaling",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"6772"
"WP585:Interferon type I signaling",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"6772"
"WP61:Notch signaling",0.0103092783505155,8.61819603127511,8.31018518518519,0.113638762835788,0.176543783196638,"51107"
"hsa03013_Nucleocytoplasmic_transport",0.0133333333333333,8.79956832669465,8.31018518518519,0.02415240025853,0.0929903184633895,"1915, 7919"
"R-HSA-9843745~Adipogenesis",0.0132450331125828,8.7168799894147,8.23394495412844,0.0245694848328766,0.0937567672519203,"1019, 1108"
"GO:0030968~endoplasmic reticulum unfolded protein response",0.0102040816326531,8.45816900359849,8.15909090909091,0.115619357748958,0.178673374580404,"3309"
"GO:0033209~tumor necrosis factor-mediated signaling pathway",0.0102040816326531,8.45816900359849,8.15909090909091,0.115619357748958,0.178673374580404,"6772"
"GO:0005005~transmembrane-ephrin receptor activity",0.0102040816326531,8.45816900359849,8.15909090909091,0.115619357748958,0.178673374580404,"780"
"R-HSA-109606~Intrinsic Pathway for Apoptosis",0.0102040816326531,8.45816900359849,8.15909090909091,0.115619357748958,0.178673374580404,"598"
"WP4879:Overlap between signal transduction pathways contributing to LMNA laminopathies",0.0102040816326531,8.45816900359849,8.15909090909091,0.115619357748958,0.178673374580404,"1019"
"hsa05020_Prion_disease",0.0158227848101266,9.15424793424034,8.10018050541516,0.000363838378894327,0.0364384403839562,"3309, 4697, 4720, 5715, 6391"
"GO:0005200~structural constituent of cytoskeleton",0.0130718954248366,8.55597095528511,8.08558558558559,0.0254125239176927,0.0946443591636569,"7170, 7283"
"GO:0006633~fatty acid biosynthetic process",0.0101010101010101,8.30590083706652,8.01339285714286,0.11759562734058,0.18001838459138,"31"
"GO:0048012~hepatocyte growth factor receptor signaling pathway",0.0101010101010101,8.30590083706652,8.01339285714286,0.11759562734058,0.18001838459138,"780"
"KW-0021~Allosteric enzyme",0.0101010101010101,8.30590083706652,8.01339285714286,0.11759562734058,0.18001838459138,"31"
"WP5348:11p11 2 copy number variation syndrome ",0.0101010101010101,8.30590083706652,8.01339285714286,0.11759562734058,0.18001838459138,"977"
"WP4324:Mitochondrial complex I assembly model OXPHOS system",0.0101010101010101,8.30590083706652,8.01339285714286,0.11759562734058,0.18001838459138,"4720"
"hsa05134_Legionellosis",0.0101010101010101,8.30590083706652,8.01339285714286,0.11759562734058,0.18001838459138,"1915"
"hsa05145_Toxoplasmosis",0.012987012987013,8.48008137747203,8.01339285714286,0.0258384492293995,0.0946443591636569,"598, 6772"
"hsa05225_Hepatocellular_carcinoma",0.0142857142857143,8.60683606450519,7.96597633136095,0.00630759826430696,0.065587631845631,"1019, 2002, 598"
"R-HSA-977225~Amyloid fiber formation",0.0129032258064516,8.4006571631036,7.94247787610619,0.0262672923344055,0.0946443591636569,"23163, 51107"
"hsa05208_Chemical_carcinogenesis",0.0150375939849624,8.77074833633525,7.94247787610619,0.00158475981772563,0.0626674317376895,"4697, 4720, 6391, 7422"
"GO:0006406~mRNA export from nucleus",0.01,8.15536186890102,7.87280701754386,0.119567580837306,0.181497561885037,"7919"
"GO:0007052~mitotic spindle organization",0.01,8.15536186890102,7.87280701754386,0.119567580837306,0.181497561885037,"7283"
"GO:0009612~response to mechanical stimulus",0.01,8.15536186890102,7.87280701754386,0.119567580837306,0.181497561885037,"6772"
"GO:0006612~protein targeting to membrane",0.01,8.15536186890102,7.87280701754386,0.119567580837306,0.181497561885037,"51114"
"GO:0071230~cellular response to amino acid stimulus",0.01,8.15536186890102,7.87280701754386,0.119567580837306,0.181497561885037,"598"
"R-HSA-187037~Signaling by NTRK1 (TRKA)",0.0128205128205128,8.32572742997218,7.87280701754386,0.0266990387525431,0.0954002238353066,"1108, 2002"
"R-HSA-168643~Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.01,8.15536186890102,7.87280701754386,0.119567580837306,0.181497561885037,"598"
"hsa01212_Fatty_acid_metabolism",0.01,8.15536186890102,7.87280701754386,0.119567580837306,0.181497561885037,"31"
"GO:0007259~cell surface receptor signaling pathway via JAK-STAT",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"6772"
"GO:0007584~response to nutrient",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"6772"
"GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"780"
"GO:0044183~protein folding chaperone",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"3309"
"R-HSA-446728~Cell junction organization",0.0126582278481013,8.18063096980446,7.73706896551724,0.0275711838446502,0.0982768475241183,"50848, 977"
"R-HSA-9694635~Translation of Structural Proteins",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"51114"
"R-HSA-2894858~Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"51107"
"R-HSA-186797~Signaling by PDGF",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"6772"
"R-HSA-1236394~Signaling by ERBB4",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"51107"
"R-HSA-2644606~Constitutive Signaling by NOTCH1 PEST Domain Mutants",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"51107"
"R-HSA-2644602~Signaling by NOTCH1 PEST Domain Mutants in Cancer",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"51107"
"R-HSA-2644603~Signaling by NOTCH1 in Cancer",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"51107"
"R-HSA-2894862~Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"51107"
"R-HSA-72187~mRNA 3'-end processing",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"7919"
"WP4816:TGF beta receptor signaling in skeletal dysplasias",0.0099009900990099,8.01344533721411,7.73706896551724,0.121535227446568,0.181497561885037,"6772"
"GO:0001666~response to hypoxia",0.0138888888888889,8.30537666044012,7.69285714285714,0.00694336033882976,0.0673643900422888,"57085, 7422, 9777"
"GO:0032024~positive regulation of insulin secretion",0.00980392156862745,7.87346174572934,7.60593220338983,0.123498576356628,0.183308423872806,"5715"
"GO:0010507~negative regulation of autophagy",0.00980392156862745,7.87346174572934,7.60593220338983,0.123498576356628,0.183308423872806,"598"
"R-HSA-9707564~Cytoprotection by HMOX1",0.00980392156862745,7.87346174572934,7.60593220338983,0.123498576356628,0.183308423872806,"4697"
"R-HSA-8939902~Regulation of RUNX2 expression and activity",0.00980392156862745,7.87346174572934,7.60593220338983,0.123498576356628,0.183308423872806,"6772"
"hsa05213_Endometrial_cancer",0.00980392156862745,7.87346174572934,7.60593220338983,0.123498576356628,0.183308423872806,"2002"
"GO:0031072~heat shock protein binding",0.00970873786407767,7.73969699730465,7.47916666666667,0.125457636736608,0.184904867021259,"3309"
"WP5352:10q11 21q11 23 copy number variation syndrome",0.00970873786407767,7.73969699730465,7.47916666666667,0.125457636736608,0.184904867021259,"2002"
"WP5470:Effect of omega 3 PUFA on Huntington 39 s disease pathways",0.0123456790123457,7.90016087483313,7.47916666666667,0.0293496819095811,0.100696215450905,"2002, 598"
"WP5222:2q13 copy number variation syndrome",0.00970873786407767,7.73969699730465,7.47916666666667,0.125457636736608,0.184904867021259,"6772"
"hsa04370_VEGF_signaling_pathway",0.00970873786407767,7.73969699730465,7.47916666666667,0.125457636736608,0.184904867021259,"7422"
"GO:0000165~MAPK cascade",0.0121951219512195,7.76780230251152,7.35655737704918,0.0302558073472778,0.102184136748646,"4296, 51114"
"R-HSA-2022090~Assembly of collagen fibrils and other multimeric structures",0.00961538461538462,7.61042333670674,7.35655737704918,0.127412417736538,0.187597177873394,"977"
"hsa05014_Amyotrophic_lateral_sclerosis",0.0147420147420147,8.40882560984365,7.29674796747967,0.000158496216350954,0.0281587731038871,"3309, 4697, 4720, 5715, 598, 6391"
"GO:0030674~protein-macromolecule adaptor activity",0.0132743362831858,7.84496684251027,7.27702702702703,0.00808516329711842,0.0702207499359569,"126298, 51107, 8508"
"R-HSA-1234174~Cellular response to hypoxia",0.00952380952380952,7.48543233809546,7.23790322580645,0.12936292848738,0.189138413407198,"7422"
"R-HSA-8943724~Regulation of PTEN gene transcription",0.00952380952380952,7.48543233809546,7.23790322580645,0.12936292848738,0.189138413407198,"1108"
"WP3863:T cell antigen receptor TCR pathway during Staphylococcus aureus infection",0.00952380952380952,7.48543233809546,7.23790322580645,0.12936292848738,0.189138413407198,"1019"
"WP183:Proteasome degradation",0.00952380952380952,7.48543233809546,7.23790322580645,0.12936292848738,0.189138413407198,"5715"
"WP5402:10q22q23 copy number variation",0.00952380952380952,7.48543233809546,7.23790322580645,0.12936292848738,0.189138413407198,"7422"
"hsa04330_Notch_signaling_pathway",0.00952380952380952,7.48543233809546,7.23790322580645,0.12936292848738,0.189138413407198,"51107"
"GO:0010595~positive regulation of endothelial cell migration",0.00943396226415094,7.36452596717494,7.12301587301587,0.131309178101085,0.191030730802472,"7422"
"R-HSA-450294~MAP kinase activation",0.00943396226415094,7.36452596717494,7.12301587301587,0.131309178101085,0.191030730802472,"2002"
"R-HSA-1226099~Signaling by FGFR in disease",0.00943396226415094,7.36452596717494,7.12301587301587,0.131309178101085,0.191030730802472,"6772"
"WP4155:Endometrial cancer",0.00943396226415094,7.36452596717494,7.12301587301587,0.131309178101085,0.191030730802472,"2002"
"GO:0042826~histone deacetylase binding",0.0118343195266272,7.45562408287693,7.06692913385827,0.0325694409888767,0.105304921408581,"1108, 112939"
"WP2003:miR targeted genes in leukocytes",0.0118343195266272,7.45562408287693,7.06692913385827,0.0325694409888767,0.105304921408581,"1075, 7170"
"GO:0043525~positive regulation of neuron apoptotic process",0.00934579439252336,7.24751517301697,7.01171875,0.133251175670618,0.193088993429729,"4296"
"GO:0042393~histone binding",0.0128755364806867,7.55214336615308,7.01171875,0.0089465914681368,0.0702207499359569,"1108, 6772, 8125"
"WP45:G1 to S cell cycle control",0.00934579439252336,7.24751517301697,7.01171875,0.133251175670618,0.193088993429729,"1019"
"R-HSA-114608~Platelet degranulation ",0.0116959064327485,7.33772453420888,6.95736434108527,0.0335139301534218,0.106967119117131,"3309, 7422"
"GO:0001570~vasculogenesis",0.00925925925925926,7.13421917239613,6.90384615384615,0.135188930270003,0.195317340084373,"7422"
"KW-0514~Muscle protein",0.00925925925925926,7.13421917239613,6.90384615384615,0.135188930270003,0.195317340084373,"7170"
"hsa05167_Kaposi_sarcoma-associated_herpesvirus_infection",0.0127118644067797,7.43326205333346,6.90384615384615,0.00933165412138252,0.0703557202778735,"1019, 6772, 7422"
"GO:0032981~mitochondrial respiratory chain complex I assembly",0.00917431192660551,7.02446512236246,6.79924242424242,0.137122450954359,0.196560069127335,"4720"
"GO:0051289~protein homotetramerization",0.00917431192660551,7.02446512236246,6.79924242424242,0.137122450954359,0.196560069127335,"31"
"GO:0004197~cysteine-type endopeptidase activity",0.00917431192660551,7.02446512236246,6.79924242424242,0.137122450954359,0.196560069127335,"1075"
"R-HSA-9614085~FOXO-mediated transcription",0.00917431192660551,7.02446512236246,6.79924242424242,0.137122450954359,0.196560069127335,"4800"
"WP3680:Physico chemical features and toxicity associated pathways",0.00917431192660551,7.02446512236246,6.79924242424242,0.137122450954359,0.196560069127335,"2002"
"WP2324:AGE RAGE pathway",0.00917431192660551,7.02446512236246,6.79924242424242,0.137122450954359,0.196560069127335,"6772"
"WP5039:SARS CoV 2 innate immunity evasion and cell specific immune response",0.00917431192660551,7.02446512236246,6.79924242424242,0.137122450954359,0.196560069127335,"6772"
"hsa05321_Inflammatory_bowel_disease",0.00917431192660551,7.02446512236246,6.79924242424242,0.137122450954359,0.196560069127335,"6772"
"hsa05165_Human_papillomavirus_infection",0.0134770889487871,7.59445644846998,6.75828313253012,0.000827085085558259,0.048772494698828,"1019, 1108, 6772, 7283, 7422"
"R-HSA-166520~Signaling by NTRKs",0.0114285714285714,7.11287667131119,6.74812030075188,0.0354349352035955,0.109288800154247,"1108, 2002"
"hsa04142_Lysosome",0.0114285714285714,7.11287667131119,6.74812030075188,0.0354349352035955,0.109288800154247,"1075, 23163"
"R-HSA-9006934~Signaling by Receptor Tyrosine Kinases",0.0140350877192982,8.09922893668117,6.72284644194757,2.04141559357737e-05,0.00827047957962596,"1108, 2002, 23163, 26018, 3185, 51107, 6772, 7422"
"GO:0001817~regulation of cytokine production",0.00909090909090909,6.91516808266926,6.69776119402985,0.139051746759939,0.198355218114227,"50848"
"R-HSA-6802952~Signaling by BRAF and RAF1 fusions",0.00909090909090909,6.91516808266926,6.69776119402985,0.139051746759939,0.198355218114227,"57085"
"R-HSA-76005~Response to elevated platelet cytosolic Ca2+",0.0113636363636364,7.05882277787481,6.69776119402985,0.035921779163397,0.110557576626842,"3309, 7422"
"R-HSA-73856~RNA Polymerase II Transcription Termination",0.00909090909090909,6.91516808266926,6.69776119402985,0.139051746759939,0.198355218114227,"7919"
"WP1403:AMP activated protein kinase signaling",0.00909090909090909,6.91516808266926,6.69776119402985,0.139051746759939,0.198355218114227,"31"
"GO:0046777~protein autophosphorylation",0.0112359550561798,6.95021499477158,6.59926470588235,0.0369032835853046,0.110682724522668,"4296, 780"
"GO:0003684~damaged DNA binding",0.00900900900900901,6.81209699882819,6.59926470588235,0.140976826704169,0.200905691752537,"7374"
"hsa05415_Diabetic_cardiomyopathy",0.0122448979591837,7.09508839056746,6.59926470588235,0.0105446456719665,0.0703557202778735,"4697, 4720, 6391"
"WP2380:Brain derived neurotrophic factor BDNF signaling",0.0111731843575419,6.89861631119106,6.55109489051095,0.0373979171595361,0.110682724522668,"2002, 6772"
"hsa04210_Apoptosis",0.0111731843575419,6.89861631119106,6.55109489051095,0.0373979171595361,0.110682724522668,"1075, 598"
"GO:0001938~positive regulation of endothelial cell proliferation",0.00892857142857143,6.71209217435643,6.5036231884058,0.142897699785686,0.202636148627853,"7422"
"GO:0043124~negative regulation of canonical NF-kappaB signal transduction",0.00892857142857143,6.71209217435643,6.5036231884058,0.142897699785686,0.202636148627853,"6772"
"R-HSA-6799198~Complex I biogenesis",0.00892857142857143,6.71209217435643,6.5036231884058,0.142897699785686,0.202636148627853,"4720"
"WP1530:miRNA regulation of DNA damage response",0.00892857142857143,6.71209217435643,6.5036231884058,0.142897699785686,0.202636148627853,"1019"
"WP707:DNA damage response",0.00892857142857143,6.71209217435643,6.5036231884058,0.142897699785686,0.202636148627853,"1019"
"hsa04910_Insulin_signaling_pathway",0.0111111111111111,6.84778332163979,6.5036231884058,0.0378951204582864,0.111928127966511,"2002, 31"
"GO:0050679~positive regulation of epithelial cell proliferation",0.00884955752212389,6.61490628352166,6.41071428571429,0.144814374984377,0.203601784407017,"7422"
"GO:0005518~collagen binding",0.00884955752212389,6.61490628352166,6.41071428571429,0.144814374984377,0.203601784407017,"780"
"R-HSA-5654738~Signaling by FGFR2",0.00884955752212389,6.61490628352166,6.41071428571429,0.144814374984377,0.203601784407017,"3185"
"R-HSA-3371453~Regulation of HSF1-mediated heat shock response",0.00884955752212389,6.61490628352166,6.41071428571429,0.144814374984377,0.203601784407017,"3309"
"WP5130:Th17 cell differentiation pathway",0.00884955752212389,6.61490628352166,6.41071428571429,0.144814374984377,0.203601784407017,"6772"
"hsa05120_Epithelial_cell_signaling_in_Helicobacter_pylori_infection",0.00884955752212389,6.61490628352166,6.41071428571429,0.144814374984377,0.203601784407017,"50848"
"hsa05211_Renal_cell_carcinoma",0.00884955752212389,6.61490628352166,6.41071428571429,0.144814374984377,0.203601784407017,"7422"
"KW-0037~Angiogenesis",0.0109289617486339,6.69970339909455,6.36524822695035,0.0394020155952915,0.113629828439177,"7422, 80155"
"GO:0045669~positive regulation of osteoblast differentiation",0.0087719298245614,6.52009060942972,6.32042253521127,0.146726861261413,0.204329706984762,"7422"
"R-HSA-448424~Interleukin-17 signaling",0.0087719298245614,6.52009060942972,6.32042253521127,0.146726861261413,0.204329706984762,"2002"
"R-HSA-380259~Loss of Nlp from mitotic centrosomes",0.0087719298245614,6.52009060942972,6.32042253521127,0.146726861261413,0.204329706984762,"7283"
"R-HSA-380284~Loss of proteins required for interphase microtubule organization from the centrosome",0.0087719298245614,6.52009060942972,6.32042253521127,0.146726861261413,0.204329706984762,"7283"
"R-HSA-204005~COPII-mediated vesicle transport",0.0087719298245614,6.52009060942972,6.32042253521127,0.146726861261413,0.204329706984762,"1075"
"R-HSA-9772573~Late SARS-CoV-2 Infection Events",0.0087719298245614,6.52009060942972,6.32042253521127,0.146726861261413,0.204329706984762,"51114"
"KW-0347~Helicase",0.0108695652173913,6.65153283891174,6.32042253521127,0.0399093649065222,0.114417259467818,"1108, 7919"
"hsa04917_Prolactin_signaling_pathway",0.0087719298245614,6.52009060942972,6.32042253521127,0.146726861261413,0.204329706984762,"6772"
"hsa05017_Spinocerebellar_ataxia",0.0108108108108108,6.60402934646224,6.27622377622378,0.0404192177198061,0.115201873585355,"4800, 5715"
"WP3888:VEGFA VEGFR2 signaling",0.0127931769722814,7.15841232697464,6.24709976798144,0.000365343557258176,0.0364384403839562,"2002, 31, 598, 6772, 7170, 7422"
"GO:0006909~phagocytosis",0.00869565217391304,6.42794350978263,6.23263888888889,0.148635167559293,0.205813346384087,"9777"
"GO:0003724~RNA helicase activity",0.00869565217391304,6.42794350978263,6.23263888888889,0.148635167559293,0.205813346384087,"7919"
"R-HSA-9821002~Chromatin modifications during the maternal to zygotic transition (MZT)",0.00869565217391304,6.42794350978263,6.23263888888889,0.148635167559293,0.205813346384087,"7374"
"WP4255:Non small cell lung cancer",0.00869565217391304,6.42794350978263,6.23263888888889,0.148635167559293,0.205813346384087,"1019"
"WP2572:Primary focal segmental glomerulosclerosis FSGS ",0.00869565217391304,6.42794350978263,6.23263888888889,0.148635167559293,0.205813346384087,"977"
"R-HSA-9678108~SARS-CoV-1 Infection",0.0106951871657754,6.51101411828485,6.18965517241379,0.0414463814452706,0.115201873585355,"1915, 598"
"R-HSA-1980143~Signaling by NOTCH1",0.00862068965517241,6.33835416817484,6.1472602739726,0.150539302801879,0.207274509966873,"51107"
"R-HSA-69202~Cyclin E associated events during G1/S transition ",0.00862068965517241,6.33835416817484,6.1472602739726,0.150539302801879,0.207274509966873,"1019"
"KW-1183~Host cell receptor for virus entry",0.00862068965517241,6.33835416817484,6.1472602739726,0.150539302801879,0.207274509966873,"50848"
"WP3584:MECP2 and associated Rett syndrome",0.00862068965517241,6.33835416817484,6.1472602739726,0.150539302801879,0.207274509966873,"3185"
"hsa05218_Melanoma",0.00862068965517241,6.33835416817484,6.1472602739726,0.150539302801879,0.207274509966873,"1019"
"hsa05223_Non-small_cell_lung_cancer",0.00862068965517241,6.33835416817484,6.1472602739726,0.150539302801879,0.207274509966873,"1019"
"GO:0043484~regulation of RNA splicing",0.00854700854700855,6.25121789170457,6.06418918918919,0.152439275894433,0.208713588023686,"3185"
"R-HSA-8854518~AURKA Activation by TPX2",0.00854700854700855,6.25121789170457,6.06418918918919,0.152439275894433,0.208713588023686,"7283"
"R-HSA-1169408~ISG15 antiviral mechanism",0.00854700854700855,6.25121789170457,6.06418918918919,0.152439275894433,0.208713588023686,"6772"
"R-HSA-9013408~RHOG GTPase cycle",0.00854700854700855,6.25121789170457,6.06418918918919,0.152439275894433,0.208713588023686,"4296"
"WP5055:Burn wound healing",0.00854700854700855,6.25121789170457,6.06418918918919,0.152439275894433,0.208713588023686,"7422"
"hsa04723_Retrograde_endocannabinoid_signaling",0.0105263157894737,6.37626669705782,6.06418918918919,0.0430055768963624,0.118004945397602,"4697, 4720"
"hsa05166_Human_T-cell_leukemia_virus_1_infection",0.0113207547169811,6.44786905848073,6.01004464285714,0.0135555812505307,0.0769725834574709,"1019, 2002, 598"
"GO:0031398~positive regulation of protein ubiquitination",0.00847457627118644,6.16643567776224,5.98333333333333,0.154335095723656,0.210326432776889,"3309"
"R-HSA-69656~Cyclin A:Cdk2-associated events at S phase entry",0.00847457627118644,6.16643567776224,5.98333333333333,0.154335095723656,0.210326432776889,"1019"
"R-HSA-450531~Regulation of mRNA stability by proteins that bind AU-rich elements",0.00847457627118644,6.16643567776224,5.98333333333333,0.154335095723656,0.210326432776889,"8125"
"hsa01524_Platinum_drug_resistance",0.00847457627118644,6.16643567776224,5.98333333333333,0.154335095723656,0.210326432776889,"598"
"hsa04918_Thyroid_hormone_synthesis",0.00847457627118644,6.16643567776224,5.98333333333333,0.154335095723656,0.210326432776889,"3309"
"hsa05163_Human_cytomegalovirus_infection",0.0112359550561798,6.38939358411713,5.95685840707965,0.0138809175454611,0.078213631554233,"1019, 2002, 7422"
"WP4666:Hepatitis B infection",0.0103626943005181,6.24694323373951,5.94370860927152,0.0445866019059228,0.1202935023797,"2002, 6772"
"GO:0008217~regulation of blood pressure",0.00840336134453781,6.08392546812645,5.90460526315789,0.156226771157726,0.211136734083089,"57085"
"GO:0030163~protein catabolic process",0.00840336134453781,6.08392546812645,5.90460526315789,0.156226771157726,0.211136734083089,"23163"
"GO:0006936~muscle contraction",0.00840336134453781,6.08392546812645,5.90460526315789,0.156226771157726,0.211136734083089,"7170"
"R-HSA-9009391~Extra-nuclear estrogen signaling",0.00840336134453781,6.08392546812645,5.90460526315789,0.156226771157726,0.211136734083089,"2002"
"R-HSA-9013694~Signaling by NOTCH4",0.00840336134453781,6.08392546812645,5.90460526315789,0.156226771157726,0.211136734083089,"51107"
"R-HSA-159236~Transport of Mature mRNA derived from an Intron-Containing Transcript",0.00840336134453781,6.08392546812645,5.90460526315789,0.156226771157726,0.211136734083089,"7919"
"KW-0511~Multifunctional enzyme",0.00840336134453781,6.08392546812645,5.90460526315789,0.156226771157726,0.211136734083089,"31"
"WP4341:Non genomic actions of 1 25 dihydroxyvitamin D3",0.00840336134453781,6.08392546812645,5.90460526315789,0.156226771157726,0.211136734083089,"6772"
"hsa05214_Glioma",0.00840336134453781,6.08392546812645,5.90460526315789,0.156226771157726,0.211136734083089,"1019"
"R-HSA-5663202~Diseases of signal transduction by growth factor receptors and second messengers",0.0120967741935484,6.7223794511731,5.87882096069869,0.000504092255320218,0.0398103944017643,"4296, 51107, 57085, 598, 6772, 7170"
"R-HSA-8957322~Metabolism of steroids",0.0102564102564103,6.16360182025471,5.86601307189542,0.0456525751696324,0.120871970592096,"31, 4800"
"R-HSA-1500931~Cell-Cell communication",0.0102564102564103,6.16360182025471,5.86601307189542,0.0456525751696324,0.120871970592096,"50848, 977"
"KW-0945~Host-virus interaction",0.0124137931034483,7.17920624569671,5.85326086956522,1.74620657447315e-05,0.00827047957962596,"1915, 3309, 50848, 51114, 6772, 7374, 8125, 9144, 977"
"GO:0001558~regulation of cell growth",0.00833333333333333,6.00359293512197,5.82792207792208,0.158114311046335,0.212706580057742,"780"
"GO:0071346~cellular response to type II interferon",0.00833333333333333,6.00359293512197,5.82792207792208,0.158114311046335,0.212706580057742,"6772"
"GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation",0.00833333333333333,6.00359293512197,5.82792207792208,0.158114311046335,0.212706580057742,"7422"
"R-HSA-909733~Interferon alpha/beta signaling",0.00833333333333333,6.00359293512197,5.82792207792208,0.158114311046335,0.212706580057742,"6772"
"R-HSA-204998~Cell death signalling via NRAGE, NRIF and NADE",0.00833333333333333,6.00359293512197,5.82792207792208,0.158114311046335,0.212706580057742,"51107"
"hsa05016_Huntington_disease",0.0114285714285714,6.33659593362339,5.79032258064516,0.00493648216035199,0.065587631845631,"4697, 4720, 5715, 6391"
"hsa04714_Thermogenesis",0.0109489051094891,6.19277098264691,5.77789699570815,0.0150546578682636,0.0799422079152219,"4697, 4720, 6391"
"GO:0042060~wound healing",0.00826446280991736,5.92534820782426,5.75320512820513,0.159997724220728,0.214845706675864,"7170"
"R-HSA-427389~ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression",0.00826446280991736,5.92534820782426,5.75320512820513,0.159997724220728,0.214845706675864,"1108"
"hsa05010_Alzheimer_disease",0.0116550116550117,6.43059185316436,5.75320512820513,0.00168949407217188,0.0626674317376895,"4697, 4720, 51107, 5715, 6391"
"WP706:Sudden infant death syndrome SIDS susceptibility pathways",0.0100502512562814,6.00336385671609,5.71656050955414,0.0478127605825224,0.122946398619255,"4800, 7422"
"GO:0051028~mRNA transport",0.00819672131147541,5.84911075573157,5.68037974683544,0.161877019493738,0.216575190464225,"7919"
"R-HSA-9833482~PKR-mediated signaling",0.00819672131147541,5.84911075573157,5.68037974683544,0.161877019493738,0.216575190464225,"6772"
"R-HSA-3214858~RMTs methylate histone arginines",0.00819672131147541,5.84911075573157,5.68037974683544,0.161877019493738,0.216575190464225,"1019"
"hsa04014_Ras_signaling_pathway",0.010752688172043,6.05949655582894,5.65651260504202,0.0159265713253453,0.0818681648829151,"2002, 598, 7422"
"WP437:EGF EGFR signaling",0.00995024875621891,5.92630776385109,5.64465408805031,0.0489067715144914,0.125040873069337,"2002, 6772"
"hsa05160_Hepatitis_C",0.00995024875621891,5.92630776385109,5.64465408805031,0.0489067715144914,0.125040873069337,"1019, 6772"
"GO:0045296~cadherin binding",0.011142061281337,6.15275155539039,5.6269592476489,0.00545874131598491,0.065587631845631,"11313, 3309, 50848, 6772"
"GO:0071260~cellular response to mechanical stimulus",0.00813008130081301,5.77480410073295,5.609375,0.163752205659826,0.218684577294116,"50848"
"GO:0006952~defense response",0.00813008130081301,5.77480410073295,5.609375,0.163752205659826,0.218684577294116,"6772"
"GO:0005178~integrin binding",0.0099009900990099,5.88851142501693,5.609375,0.0494572128519147,0.125789612548707,"50848, 977"
"R-HSA-9006936~Signaling by TGFB family members",0.0099009900990099,5.88851142501693,5.609375,0.0494572128519147,0.125789612548707,"50848, 51107"
"WP481:Insulin signaling",0.0099009900990099,5.88851142501693,5.609375,0.0494572128519147,0.125789612548707,"2002, 4296"
"hsa05022_Pathways_of_neurodegeneration",0.0115606936416185,6.38934249163138,5.5977130977131,0.000652123611709282,0.0454933852930523,"3309, 4697, 4720, 5715, 598, 6391"
"R-HSA-1474244~Extracellular matrix organization",0.0110497237569061,6.0937827162775,5.57453416149068,0.00564075306606017,0.065587631845631,"50848, 780, 8079, 977"
"KW-0276~Fatty acid metabolism",0.00985221674876847,5.85119058391454,5.57453416149068,0.0500099282399788,0.12618596336215,"11313, 31"
"GO:0016787~hydrolase activity",0.0110192837465565,6.07437290437346,5.55727554179567,0.00570231711384774,0.065587631845631,"1108, 11163, 11313, 7919"
"GO:0000082~G1/S transition of mitotic cell cycle",0.00806451612903226,5.70235557908454,5.54012345679012,0.165623291495115,0.220179784065648,"1019"
"GO:0048009~insulin-like growth factor receptor signaling pathway",0.00806451612903226,5.70235557908454,5.54012345679012,0.165623291495115,0.220179784065648,"780"
"GO:0007254~JNK cascade",0.00806451612903226,5.70235557908454,5.54012345679012,0.165623291495115,0.220179784065648,"4296"
"GO:0001618~virus receptor activity",0.00806451612903226,5.70235557908454,5.54012345679012,0.165623291495115,0.220179784065648,"50848"
"hsa05161_Hepatitis_B",0.00975609756097561,5.7779398498838,5.50613496932515,0.0511221318266833,0.128683716711497,"2002, 6772"
"GO:0042981~regulation of apoptotic process",0.0104529616724739,5.85766640004,5.47256097560976,0.0173800358482261,0.0833400575386082,"598, 6772, 8125"
"GO:0000049~tRNA binding",0.008,5.63169611855332,5.47256097560976,0.167490285757433,0.221456018623321,"1915"
"R-HSA-5628897~TP53 Regulates Metabolic Genes",0.008,5.63169611855332,5.47256097560976,0.167490285757433,0.221456018623321,"4697"
"R-HSA-9734767~Developmental Cell Lineages",0.008,5.63169611855332,5.47256097560976,0.167490285757433,0.221456018623321,"26018"
"R-HSA-380270~Recruitment of mitotic centrosome proteins and complexes",0.008,5.63169611855332,5.47256097560976,0.167490285757433,0.221456018623321,"7283"
"R-HSA-380287~Centrosome maturation",0.008,5.63169611855332,5.47256097560976,0.167490285757433,0.221456018623321,"7283"
"WP2261:Glioblastoma signaling",0.008,5.63169611855332,5.47256097560976,0.167490285757433,0.221456018623321,"1019"
"GO:0001889~liver development",0.00793650793650794,5.56276002933509,5.4066265060241,0.169353197186344,0.22351570619639,"2002"
"R-HSA-381340~Transcriptional regulation of white adipocyte differentiation",0.00793650793650794,5.56276002933509,5.4066265060241,0.169353197186344,0.22351570619639,"1019"
"R-HSA-9679506~SARS-CoV Infections",0.0109170305676856,5.97130091753876,5.35501193317422,0.00230992581149163,0.0626674317376895,"1108, 1915, 51114, 598, 6772"
"GO:0048511~rhythmic process",0.0078740157480315,5.49625754731704,5.34226190476191,0.171212034503189,0.225359955567989,"4800"
"GO:0022008~neurogenesis",0.0078740157480315,5.49625754731704,5.34226190476191,0.171212034503189,0.225359955567989,"4720"
"GO:0030165~PDZ domain binding",0.0078740157480315,5.49625754731704,5.34226190476191,0.171212034503189,0.225359955567989,"50848"
"hsa04630_JAK-STAT_signaling_pathway",0.00952380952380952,5.60253474379337,5.34226190476191,0.0539415775473164,0.130709414033877,"598, 6772"
"WP5434:Cancer pathways",0.0109689213893967,6.0249942143727,5.28978388998035,0.000875742244926437,0.048772494698828,"1019, 2002, 598, 6772, 7170, 7422"
"GO:0048013~ephrin receptor signaling pathway",0.0078125,5.43060157014616,5.27941176470588,0.173066806411121,0.226782532551245,"780"
"R-HSA-216083~Integrin cell surface interactions",0.0078125,5.43060157014616,5.27941176470588,0.173066806411121,0.226782532551245,"50848"
"R-HSA-190236~Signaling by FGFR",0.0078125,5.43060157014616,5.27941176470588,0.173066806411121,0.226782532551245,"3185"
"R-HSA-72202~Transport of Mature Transcript to Cytoplasm",0.0078125,5.43060157014616,5.27941176470588,0.173066806411121,0.226782532551245,"7919"
"WP254:Apoptosis",0.0078125,5.43060157014616,5.27941176470588,0.173066806411121,0.226782532551245,"598"
"hsa04530_Tight_junction",0.00943396226415094,5.53602238358274,5.27941176470588,0.0550846756057924,0.130709414033877,"1019, 50848"
"GO:0010508~positive regulation of autophagy",0.00775193798449612,5.3664851538815,5.21802325581395,0.174917521595145,0.22839052507744,"126298"
"R-HSA-9759194~Nuclear events mediated by NFE2L2",0.00775193798449612,5.3664851538815,5.21802325581395,0.174917521595145,0.22839052507744,"598"
"hsa04012_ErbB_signaling_pathway",0.00775193798449612,5.3664851538815,5.21802325581395,0.174917521595145,0.22839052507744,"2002"
"R-HSA-1428517~Aerobic respiration and respiratory electron transport",0.01,5.55727301923479,5.19787644787645,0.0198959966273176,0.0867489138661316,"4697, 4720, 6391"
"GO:1902600~proton transmembrane transport",0.00930232558139535,5.43812715221729,5.1878612716763,0.0568154363025602,0.131284880415222,"4697, 4720"
"hsa05164_Influenza_A",0.00930232558139535,5.43812715221729,5.1878612716763,0.0568154363025602,0.131284880415222,"1019, 6772"
"GO:0016485~protein processing",0.00769230769230769,5.30385408358543,5.15804597701149,0.176764188722151,0.229981826356972,"51107"
"WP2840:Hair follicle development cytodifferentiation stage 3 of 3",0.00769230769230769,5.30385408358543,5.15804597701149,0.176764188722151,0.229981826356972,"26018"
"WP2446:Retinoblastoma gene in cancer",0.00769230769230769,5.30385408358543,5.15804597701149,0.176764188722151,0.229981826356972,"1019"
"hsa04260_Cardiac_muscle_contraction",0.00769230769230769,5.30385408358543,5.15804597701149,0.176764188722151,0.229981826356972,"7170"
"WP5087:Pleural mesothelioma",0.0104602510460251,5.69030355049181,5.11104783599089,0.00282531820181049,0.065587631845631,"1019, 2002, 4296, 6772, 7422"
"R-HSA-2565942~Regulation of PLK1 Activity at G2/M Transition",0.00763358778625954,5.24265672381421,5.09943181818182,0.178606816440954,0.231967186246452,"7283"
"WP5098:T cell activation SARS CoV 2",0.00763358778625954,5.24265672381421,5.09943181818182,0.178606816440954,0.231967186246452,"598"
"hsa05200_Pathways_in_cancer",0.0105263157894737,5.75494679788295,5.06109022556391,0.00110040395749823,0.0575747070619609,"1019, 2002, 598, 6772, 7170, 7422"
"R-HSA-421270~Cell-cell junction organization",0.00757575757575758,5.18284387785948,5.04213483146067,0.180445413382328,0.233733448810885,"50848"
"WP231:TNF alpha signaling",0.00757575757575758,5.18284387785948,5.04213483146067,0.180445413382328,0.233733448810885,"598"
"GO:0030335~positive regulation of cell migration",0.00970873786407767,5.36603799706527,5.02332089552239,0.0217500336499379,0.0893041444912659,"3309, 7422, 977"
"R-HSA-5673001~RAF/MAP kinase cascade",0.00967741935483871,5.34553146345282,5.0046468401487,0.0219617174856083,0.0893041444912659,"4296, 51114, 598"
"GO:0051402~neuron apoptotic process",0.0075187969924812,5.1243475165208,4.98611111111111,0.182279988159047,0.234451433409134,"598"
"R-HSA-9616222~Transcriptional regulation of granulopoiesis",0.0075187969924812,5.1243475165208,4.98611111111111,0.182279988159047,0.234451433409134,"1019"
"R-HSA-1474290~Collagen formation",0.0075187969924812,5.1243475165208,4.98611111111111,0.182279988159047,0.234451433409134,"977"
"R-HSA-912446~Meiotic recombination",0.0075187969924812,5.1243475165208,4.98611111111111,0.182279988159047,0.234451433409134,"1019"
"R-HSA-156902~Peptide chain elongation",0.0075187969924812,5.1243475165208,4.98611111111111,0.182279988159047,0.234451433409134,"1915"
"WP1772:Apoptosis modulation and signaling",0.0075187969924812,5.1243475165208,4.98611111111111,0.182279988159047,0.234451433409134,"598"
"WP673:ErbB signaling",0.0075187969924812,5.1243475165208,4.98611111111111,0.182279988159047,0.234451433409134,"2002"
"hsa05235_PD-L1_expression_and_PD-1_checkpoint_pathway_in_cancer",0.0075187969924812,5.1243475165208,4.98611111111111,0.182279988159047,0.234451433409134,"6772"
"hsa05152_Tuberculosis",0.00896860986547085,5.19282237833777,4.9585635359116,0.0615230746553915,0.138238196886731,"4800, 6772"
"hsa05168_Herpes_simplex_virus_1_infection",0.00892857142857143,5.16323535799467,4.93131868131868,0.0621207562889862,0.138752116356119,"598, 6772"
"R-HSA-5684996~MAPK1/MAPK3 signaling",0.00952380952380952,5.24542868095506,4.91332116788321,0.0230371895001763,0.0927183588399953,"4296, 51114, 598"
"GO:0061629~RNA polymerase II-specific DNA-binding transcription factor binding",0.00888888888888889,5.1344726376005,4.90437158469945,0.0627204497730583,0.138752116356119,"1108, 2002"
"GO:0032869~cellular response to insulin stimulus",0.00740740740740741,5.01050129925204,4.87771739130435,0.185937105579811,0.238527022481981,"6772"
"R-HSA-2682334~EPH-Ephrin signaling",0.00740740740740741,5.01050129925204,4.87771739130435,0.185937105579811,0.238527022481981,"51107"
"WP4223:Ras signaling",0.00884955752212389,5.10628876183378,4.87771739130435,0.063322143648059,0.138752116356119,"2002, 598"
"WP23:B cell receptor signaling",0.00740740740740741,5.01050129925204,4.87771739130435,0.185937105579811,0.238527022481981,"2002"
"GO:0006396~RNA processing",0.00735294117647059,4.95623098269435,4.8252688172043,0.187759665359717,0.240024354059323,"3185"
"R-HSA-449147~Signaling by Interleukins",0.00992063492063492,5.3611259002157,4.8252688172043,0.00361440133542158,0.065587631845631,"2002, 3185, 598, 6772, 7422"
"R-HSA-9860931~Response of endothelial cells to shear stress",0.00735294117647059,4.95623098269435,4.8252688172043,0.187759665359717,0.240024354059323,"6772"
"hsa04658_Th1_and_Th2_cell_differentiation",0.00735294117647059,4.95623098269435,4.8252688172043,0.187759665359717,0.240024354059323,"6772"
"hsa04912_GnRH_signaling_pathway",0.00735294117647059,4.95623098269435,4.8252688172043,0.187759665359717,0.240024354059323,"2002"
"GO:0019899~enzyme binding",0.00968523002421308,5.23752278617276,4.81233243967828,0.00938256011671053,0.0703557202778735,"3309, 51107, 6772, 84064"
"GO:0009887~animal organ morphogenesis",0.0072992700729927,4.90158872239441,4.77393617021277,0.189578237246759,0.24129636626108,"8079"
"GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway",0.0072992700729927,4.90158872239441,4.77393617021277,0.189578237246759,0.24129636626108,"3309"
"R-HSA-156842~Eukaryotic Translation Elongation",0.0072992700729927,4.90158872239441,4.77393617021277,0.189578237246759,0.24129636626108,"1915"
"KW-0358~Heparin-binding",0.0072992700729927,4.90158872239441,4.77393617021277,0.189578237246759,0.24129636626108,"7422"
"hsa04621_NOD-like_receptor_signaling_pathway",0.00869565217391304,4.99464554477948,4.77393617021277,0.0657486952285303,0.138956350008571,"598, 6772"
"hsa05323_Rheumatoid_arthritis",0.0072992700729927,4.90158872239441,4.77393617021277,0.189578237246759,0.24129636626108,"7422"
"GO:0007411~axon guidance",0.00865800865800866,4.96779555999351,4.74867724867725,0.0663602205255596,0.138956350008571,"11313, 8079"
"R-HSA-3214815~HDACs deacetylate histones",0.0072463768115942,4.84945514053043,4.72368421052632,0.191392829764247,0.242972699830695,"1108"
"WP75:Toll like receptor signaling",0.0072463768115942,4.84945514053043,4.72368421052632,0.191392829764247,0.242972699830695,"6772"
"GO:0036503~ERAD pathway",0.00719424460431655,4.79833653130412,4.67447916666667,0.193203451417701,0.244424055550028,"3309"
"GO:0000398~mRNA splicing, via spliceosome",0.00854700854700855,4.88883704833537,4.67447916666667,0.0682063463898284,0.140886103659695,"3185, 7919"
"GO:0004386~helicase activity",0.00719424460431655,4.79833653130412,4.67447916666667,0.193203451417701,0.244424055550028,"7919"
"R-HSA-170834~Signaling by TGF-beta Receptor Complex",0.00719424460431655,4.79833653130412,4.67447916666667,0.193203451417701,0.244424055550028,"50848"
"hsa01522_Endocrine_resistance",0.00719424460431655,4.79833653130412,4.67447916666667,0.193203451417701,0.244424055550028,"1019"
"GO:0016525~negative regulation of angiogenesis",0.00714285714285714,4.74822710346191,4.62628865979381,0.195010110694897,0.24543798296222,"6772"
"GO:0034976~response to endoplasmic reticulum stress",0.00714285714285714,4.74822710346191,4.62628865979381,0.195010110694897,0.24543798296222,"3309"
"R-HSA-975871~MyD88 cascade initiated on plasma membrane",0.00714285714285714,4.74822710346191,4.62628865979381,0.195010110694897,0.24543798296222,"2002"
"R-HSA-168142~Toll Like Receptor 10 (TLR10) Cascade",0.00714285714285714,4.74822710346191,4.62628865979381,0.195010110694897,0.24543798296222,"2002"
"R-HSA-168176~Toll Like Receptor 5 (TLR5) Cascade",0.00714285714285714,4.74822710346191,4.62628865979381,0.195010110694897,0.24543798296222,"2002"
"GO:0098609~cell-cell adhesion",0.00840336134453781,4.78721099953022,4.57908163265306,0.0706943822492667,0.143333044767957,"50848, 7422"
"GO:0046330~positive regulation of JNK cascade",0.00709219858156028,4.69911363657819,4.57908163265306,0.196812816065898,0.247070073296092,"4296"
"WP5475:Hallmark of cancer sustaining proliferative signaling",0.00709219858156028,4.69911363657819,4.57908163265306,0.196812816065898,0.247070073296092,"2002"
"hsa04070_Phosphatidylinositol_signaling_system",0.00709219858156028,4.69911363657819,4.57908163265306,0.196812816065898,0.247070073296092,"9807"
"R-HSA-9711123~Cellular response to chemical stress",0.00836820083682008,4.76244081516532,4.55583756345178,0.0713210559757879,0.143523828302925,"4697, 598"
"hsa04814_Motor_proteins",0.00836820083682008,4.76244081516532,4.55583756345178,0.0713210559757879,0.143523828302925,"7170, 7283"
"GO:0051897~positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction",0.00833333333333333,4.73791949374418,4.53282828282828,0.071949573703155,0.144531178770806,"7422, 780"
"R-HSA-193704~p75 NTR receptor-mediated signalling",0.00704225352112676,4.65097799472493,4.53282828282828,0.198611575983092,0.248476480627864,"51107"
"R-HSA-5620912~Anchoring of the basal body to the plasma membrane",0.00704225352112676,4.65097799472493,4.53282828282828,0.198611575983092,0.248476480627864,"7283"
"R-HSA-380320~Recruitment of NuMA to mitotic centrosomes",0.00704225352112676,4.65097799472493,4.53282828282828,0.198611575983092,0.248476480627864,"7283"
"hsa05410_Hypertrophic_cardiomyopathy",0.00704225352112676,4.65097799472493,4.53282828282828,0.198611575983092,0.248476480627864,"7170"
"WP306:Focal adhesion",0.00829875518672199,4.71364399114818,4.51005025125628,0.0725799245451357,0.144531178770806,"2002, 7422"
"GO:0043066~negative regulation of apoptotic process",0.00929368029739777,4.98329415826105,4.49649298597194,0.00487185601589641,0.065587631845631,"3309, 598, 7374, 7422, 80155"
"GO:0043130~ubiquitin binding",0.00699300699300699,4.60379892581525,4.4875,0.200406398881225,0.250081238808343,"23163"
"R-HSA-9845323~Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)",0.00699300699300699,4.60379892581525,4.4875,0.200406398881225,0.250081238808343,"1108"
"WP5287:17q12 copy number variation syndrome",0.00699300699300699,4.60379892581525,4.4875,0.200406398881225,0.250081238808343,"31"
"hsa04010_MAPK_signaling_pathway",0.00879765395894428,4.77952471128084,4.4875,0.0290877819365134,0.100031926143174,"2002, 4296, 7422"
"hsa05205_Proteoglycans_in_cancer",0.00823045267489712,4.66573122445927,4.46517412935323,0.073846082214698,0.145801227014195,"2002, 7422"
"GO:0120162~positive regulation of cold-induced thermogenesis",0.00694444444444444,4.55745041979117,4.44306930693069,0.202197293177445,0.251886934102855,"7422"
"R-HSA-9679191~Potential therapeutics for SARS",0.00694444444444444,4.55745041979117,4.44306930693069,0.202197293177445,0.251886934102855,"1108"
"hsa04510_Focal_adhesion",0.00816326530612245,4.61844782587289,4.42118226600985,0.0751194426398911,0.146838385837221,"2002, 7422"
"GO:0032956~regulation of actin cytoskeleton organization",0.00689655172413793,4.51172573427825,4.39950980392157,0.203984267271325,0.25282314006133,"50848"
"GO:0008543~fibroblast growth factor receptor signaling pathway",0.00689655172413793,4.51172573427825,4.39950980392157,0.203984267271325,0.25282314006133,"780"
"GO:0019900~kinase binding",0.00689655172413793,4.51172573427825,4.39950980392157,0.203984267271325,0.25282314006133,"1915"
"WP399:Wnt signaling and pluripotency",0.00689655172413793,4.51172573427825,4.39950980392157,0.203984267271325,0.25282314006133,"4800"
"WP5345:1p36 copy number variation syndrome",0.00689655172413793,4.51172573427825,4.39950980392157,0.203984267271325,0.25282314006133,"7422"
"hsa05169_Epstein-Barr_virus_infection",0.00813008130081301,4.59649382947973,4.39950980392157,0.0757587970653161,0.147785136751915,"1019, 6772"
"hsa05203_Viral_carcinogenesis",0.00809716599190283,4.57349257803463,4.3780487804878,0.0763999200687972,0.148660598723874,"1019, 1108"
"GO:0007173~epidermal growth factor receptor signaling pathway",0.00684931506849315,4.46823498118851,4.35679611650485,0.205767329544912,0.253745065474155,"780"
"R-HSA-9855142~Cellular responses to mechanical stimuli",0.00684931506849315,4.46823498118851,4.35679611650485,0.205767329544912,0.253745065474155,"6772"
"R-HSA-975138~TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation",0.00684931506849315,4.46823498118851,4.35679611650485,0.205767329544912,0.253745065474155,"2002"
"WP3998:Prader Willi and Angelman syndrome",0.00684931506849315,4.46823498118851,4.35679611650485,0.205767329544912,0.253745065474155,"1019"
"hsa00564_Glycerophospholipid_metabolism",0.00684931506849315,4.46823498118851,4.35679611650485,0.205767329544912,0.253745065474155,"11313"
"hsa03015_mRNA_surveillance_pathway",0.00684931506849315,4.46823498118851,4.35679611650485,0.205767329544912,0.253745065474155,"7919"
"R-HSA-72163~mRNA Splicing - Major Pathway",0.00803212851405622,4.52822611076227,4.33574879227053,0.0776874293387964,0.149320483901981,"3185, 7919"
"GO:0000724~double-strand break repair via homologous recombination",0.00680272108843537,4.42445701240661,4.31490384615385,0.207546488362752,0.254866391828526,"1108"
"R-HSA-975155~MyD88 dependent cascade initiated on endosome",0.00680272108843537,4.42445701240661,4.31490384615385,0.207546488362752,0.254866391828526,"2002"
"KW-1278~Translocase",0.00680272108843537,4.42445701240661,4.31490384615385,0.207546488362752,0.254866391828526,"4720"
"WP4932:7q11 23 copy number variation syndrome",0.00680272108843537,4.42445701240661,4.31490384615385,0.207546488362752,0.254866391828526,"31"
"hsa04137_Mitophagy",0.00680272108843537,4.42445701240661,4.31490384615385,0.207546488362752,0.254866391828526,"598"
"R-HSA-5683057~MAPK family signaling cascades",0.00845070422535211,4.56136613582194,4.2874203821656,0.0326632646946125,0.105304921408581,"4296, 51114, 598"
"KW-0509~mRNA transport",0.00675675675675676,4.38158292218007,4.27380952380952,0.209321752071934,0.255760105742605,"7919"
"hsa04064_NF-kappa_B_signaling_pathway",0.00675675675675676,4.38158292218007,4.27380952380952,0.209321752071934,0.255760105742605,"598"
"hsa04625_C-type_lectin_receptor_signaling_pathway",0.00675675675675676,4.38158292218007,4.27380952380952,0.209321752071934,0.255760105742605,"6772"
"hsa05414_Dilated_cardiomyopathy",0.00675675675675676,4.38158292218007,4.27380952380952,0.209321752071934,0.255760105742605,"7170"
"GO:0046718~symbiont entry into host cell",0.00671140939597315,4.33956859311478,4.23349056603774,0.211093129002119,0.257280727111568,"50848"
"R-HSA-168164~Toll Like Receptor 3 (TLR3) Cascade",0.00671140939597315,4.33956859311478,4.23349056603774,0.211093129002119,0.257280727111568,"2002"
"hsa04922_Glucagon_signaling_pathway",0.00671140939597315,4.33956859311478,4.23349056603774,0.211093129002119,0.257280727111568,"31"
"GO:0008380~RNA splicing",0.0078125,4.37690206792236,4.19392523364486,0.0822478717049148,0.151754574367381,"3185, 7919"
"R-HSA-163685~Integration of energy metabolism",0.00666666666666667,4.29837601661487,4.19392523364486,0.21286062746558,0.258789061607531,"31"
"R-HSA-72172~mRNA Splicing",0.00778210116731518,4.35612229237277,4.17441860465116,0.0829061020156255,0.152163816208643,"3185, 7919"
"R-HSA-194138~Signaling by VEGF",0.00662251655629139,4.2579721271347,4.15509259259259,0.214624255757235,0.260069921161579,"7422"
"R-HSA-168181~Toll Like Receptor 7/8 (TLR7/8) Cascade",0.00662251655629139,4.2579721271347,4.15509259259259,0.214624255757235,0.260069921161579,"2002"
"R-HSA-5250913~Positive epigenetic regulation of rRNA expression",0.00662251655629139,4.2579721271347,4.15509259259259,0.214624255757235,0.260069921161579,"1108"
"hsa05417_Lipid_and_atherosclerosis",0.00775193798449612,4.33553988916543,4.15509259259259,0.083565986005139,0.15226886753424,"3309, 598"
"GO:0007169~cell surface receptor protein tyrosine kinase signaling pathway",0.00657894736842105,4.21832785537816,4.11697247706422,0.216384022154682,0.261251703310144,"780"
"GO:0008584~male gonad development",0.00657894736842105,4.21832785537816,4.11697247706422,0.216384022154682,0.261251703310144,"598"
"hsa04620_Toll-like_receptor_signaling_pathway",0.00657894736842105,4.21832785537816,4.11697247706422,0.216384022154682,0.261251703310144,"6772"
"hsa04659_Th17_cell_differentiation",0.00657894736842105,4.21832785537816,4.11697247706422,0.216384022154682,0.261251703310144,"6772"
"GO:0003690~double-stranded DNA binding",0.0065359477124183,4.17941736076242,4.07954545454545,0.218139934918239,0.262161611694192,"6772"
"R-HSA-8957275~Post-translational protein phosphorylation",0.0065359477124183,4.17941736076242,4.07954545454545,0.218139934918239,0.262161611694192,"51280"
"WP4874:CAMKK2 pathway",0.0065359477124183,4.17941736076242,4.07954545454545,0.218139934918239,0.262161611694192,"31"
"hsa04066_HIF-1_signaling_pathway",0.0065359477124183,4.17941736076242,4.07954545454545,0.218139934918239,0.262161611694192,"7422"
"WP2005:miR targeted genes in muscle cell",0.00806451612903226,4.32103291534694,4.06722054380665,0.0373014556836911,0.110682724522668,"1075, 7170, 80155"
"GO:0048018~receptor ligand activity",0.00649350649350649,4.1412174106254,4.04279279279279,0.219892002290971,0.262758387729423,"7422"
"GO:0035091~phosphatidylinositol binding",0.00649350649350649,4.1412174106254,4.04279279279279,0.219892002290971,0.262758387729423,"23163"
"R-HSA-9843940~Regulation of endogenous retroelements by KRAB-ZFP proteins",0.00649350649350649,4.1412174106254,4.04279279279279,0.219892002290971,0.262758387729423,"1108"
"R-HSA-166166~MyD88-independent TLR4 cascade ",0.00649350649350649,4.1412174106254,4.04279279279279,0.219892002290971,0.262758387729423,"2002"
"R-HSA-168138~Toll Like Receptor 9 (TLR9) Cascade",0.00649350649350649,4.1412174106254,4.04279279279279,0.219892002290971,0.262758387729423,"2002"
"R-HSA-937061~TRIF (TICAM1)-mediated TLR4 signaling ",0.00649350649350649,4.1412174106254,4.04279279279279,0.219892002290971,0.262758387729423,"2002"
"GO:0001701~in utero embryonic development",0.00754716981132075,4.19717854429986,4.02466367713004,0.0882306220944454,0.158598602905966,"598, 7422"
"GO:0016301~kinase activity",0.00754716981132075,4.19717854429986,4.02466367713004,0.0882306220944454,0.158598602905966,"1019, 4296"
"GO:0009615~response to virus",0.00645161290322581,4.10344123020156,4.00669642857143,0.221640232498733,0.264200928080264,"598"
"GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway",0.00645161290322581,4.10344123020156,4.00669642857143,0.221640232498733,0.264200928080264,"7422"
"R-HSA-9755511~KEAP1-NFE2L2 pathway",0.00645161290322581,4.10344123020156,4.00669642857143,0.221640232498733,0.264200928080264,"598"
"GO:0019722~calcium-mediated signaling",0.00641025641025641,4.0668646265358,3.9712389380531,0.2233846337502,0.264772239841459,"11163"
"R-HSA-166058~MyD88:MAL(TIRAP) cascade initiated on plasma membrane",0.00641025641025641,4.0668646265358,3.9712389380531,0.2233846337502,0.264772239841459,"2002"
"R-HSA-73854~RNA Polymerase I Promoter Clearance",0.00641025641025641,4.0668646265358,3.9712389380531,0.2233846337502,0.264772239841459,"1108"
"R-HSA-2559582~Senescence-Associated Secretory Phenotype (SASP)",0.00641025641025641,4.0668646265358,3.9712389380531,0.2233846337502,0.264772239841459,"1019"
"R-HSA-168188~Toll Like Receptor TLR6:TLR2 Cascade",0.00641025641025641,4.0668646265358,3.9712389380531,0.2233846337502,0.264772239841459,"2002"
"WP4172:PI3K Akt signaling",0.00789473684210526,4.21646811018828,3.9712389380531,0.0395957823693155,0.113964285208344,"1019, 598, 7422"
"WP3391:Senescence associated secretory phenotype SASP ",0.00641025641025641,4.0668646265358,3.9712389380531,0.2233846337502,0.264772239841459,"1019"
"KW-0143~Chaperone",0.00743494423791822,4.1211852578008,3.95374449339207,0.0909309522144754,0.162792950199613,"3309, 5715"
"GO:0006631~fatty acid metabolic process",0.00636942675159236,4.03034163556081,3.93640350877193,0.225125214236905,0.266189216188108,"11313"
"GO:0045471~response to ethanol",0.00636942675159236,4.03034163556081,3.93640350877193,0.225125214236905,0.266189216188108,"2002"
"R-HSA-73864~RNA Polymerase I Transcription",0.00636942675159236,4.03034163556081,3.93640350877193,0.225125214236905,0.266189216188108,"1108"
"R-HSA-8953897~Cellular responses to stimuli",0.00840336134453781,4.59810065946311,3.91921397379913,0.000833249013145564,0.048772494698828,"1019, 1915, 3309, 4697, 4800, 598, 6772, 7422"
"GO:0051082~unfolded protein binding",0.00632911392405063,3.99512425861741,3.90217391304348,0.226861982133272,0.268026454697777,"3309"
"R-HSA-2262752~Cellular responses to stress",0.00831353919239905,4.48107033797535,3.90217391304348,0.00187217824775217,0.0626674317376895,"1019, 1915, 3309, 4697, 4800, 598, 7422"
"R-HSA-157118~Signaling by NOTCH",0.00732600732600733,4.0484752176002,3.88528138528139,0.0936558148842527,0.164318285994527,"51107, 6772"
"GO:0035401~histone H3Y41 kinase activity",0.00628930817610063,3.96018983387452,3.86853448275862,0.228594945596651,0.268342624438377,"780"
"GO:0004713~protein tyrosine kinase activity",0.00628930817610063,3.96018983387452,3.86853448275862,0.228594945596651,0.268342624438377,"4296"
"GO:0140801~histone H2AXY142 kinase activity",0.00628930817610063,3.96018983387452,3.86853448275862,0.228594945596651,0.268342624438377,"780"
"R-HSA-168179~Toll Like Receptor TLR1:TLR2 Cascade",0.00628930817610063,3.96018983387452,3.86853448275862,0.228594945596651,0.268342624438377,"2002"
"R-HSA-181438~Toll Like Receptor 2 (TLR2) Cascade",0.00628930817610063,3.96018983387452,3.86853448275862,0.228594945596651,0.268342624438377,"2002"
"KW-0829~Tyrosine-protein kinase",0.00628930817610063,3.96018983387452,3.86853448275862,0.228594945596651,0.268342624438377,"780"
"hsa01200_Carbon_metabolism",0.00628930817610063,3.96018983387452,3.86853448275862,0.228594945596651,0.268342624438377,"6391"
"hsa04670_Leukocyte_transendothelial_migration",0.00628930817610063,3.96018983387452,3.86853448275862,0.228594945596651,0.268342624438377,"50848"
"GO:0007219~Notch signaling pathway",0.00625,3.92585929937831,3.83547008547009,0.230324112767355,0.269724080898621,"51107"
"R-HSA-1989781~PPARA activates gene expression",0.00625,3.92585929937831,3.83547008547009,0.230324112767355,0.269724080898621,"4800"
"hsa03082_ATP-dependent_chromatin_remodeling",0.00625,3.92585929937831,3.83547008547009,0.230324112767355,0.269724080898621,"1108"
"GO:0008286~insulin receptor signaling pathway",0.0062111801242236,3.89211809145021,3.80296610169492,0.232049491768692,0.271094501946678,"780"
"R-HSA-400206~Regulation of lipid metabolism by PPARalpha",0.0062111801242236,3.89211809145021,3.80296610169492,0.232049491768692,0.271094501946678,"4800"
"WP3931:Embryonic stem cell pluripotency pathways",0.0062111801242236,3.89211809145021,3.80296610169492,0.232049491768692,0.271094501946678,"2002"
"GO:0051607~defense response to virus",0.00716845878136201,3.94392577409109,3.78691983122363,0.0977877434932691,0.168342002605922,"598, 6772"
"GO:0045893~positive regulation of DNA-templated transcription",0.00798934753661784,4.24133086793302,3.77629733520337,0.00475939751713265,0.065587631845631,"1108, 2002, 4800, 5715, 6772, 80155"
"GO:0010976~positive regulation of neuron projection development",0.00617283950617284,3.85895218043431,3.77100840336134,0.233771090707,0.272670897998213,"780"
"GO:0000976~transcription cis-regulatory region binding",0.00714285714285714,3.92702014622641,3.77100840336134,0.0984814822404549,0.169167115481653,"2002, 4800"
"WP4787:Osteoblast differentiation and related diseases",0.00617283950617284,3.85895218043431,3.77100840336134,0.233771090707,0.272670897998213,"6772"
"GO:0001822~kidney development",0.00613496932515337,3.82634799186024,3.73958333333333,0.235488917671685,0.274020067028609,"7422"
"WP179:Cell cycle",0.00613496932515337,3.82634799186024,3.73958333333333,0.235488917671685,0.274020067028609,"1019"
"WP2431:Spinal cord injury",0.00613496932515337,3.82634799186024,3.73958333333333,0.235488917671685,0.274020067028609,"1019"
"hsa04151_PI3K-Akt_signaling_pathway",0.00744416873449132,3.94173239574569,3.7189226519337,0.0465849419557007,0.122746294901262,"1019, 598, 7422"
"R-HSA-69206~G1/S Transition",0.00609756097560976,3.79429234627273,3.70867768595041,0.237202980735249,0.275576817428342,"1019"
"WP4946:DNA repair pathways full network",0.00609756097560976,3.79429234627273,3.70867768595041,0.237202980735249,0.275576817428342,"7374"
"R-HSA-1500620~Meiosis",0.00606060606060606,3.76277241385504,3.67827868852459,0.238913287953331,0.275814000671103,"1019"
"R-HSA-9816359~Maternal to zygotic transition (MZT)",0.00606060606060606,3.76277241385504,3.67827868852459,0.238913287953331,0.275814000671103,"7374"
"WP2006:miR targeted genes in squamous cell",0.00606060606060606,3.76277241385504,3.67827868852459,0.238913287953331,0.275814000671103,"7170"
"WP4549:Fragile X syndrome",0.00606060606060606,3.76277241385504,3.67827868852459,0.238913287953331,0.275814000671103,"1915"
"hsa04152_AMPK_signaling_pathway",0.00606060606060606,3.76277241385504,3.67827868852459,0.238913287953331,0.275814000671103,"31"
"hsa04660_T_cell_receptor_signaling_pathway",0.00606060606060606,3.76277241385504,3.67827868852459,0.238913287953331,0.275814000671103,"1019"
"hsa04919_Thyroid_hormone_signaling_pathway",0.00606060606060606,3.76277241385504,3.67827868852459,0.238913287953331,0.275814000671103,"6772"
"hsa04935_Growth_hormone_synthesis,_secretion_and_action",0.00606060606060606,3.76277241385504,3.67827868852459,0.238913287953331,0.275814000671103,"6772"
"R-HSA-373760~L1CAM interactions",0.00602409638554217,3.73177568069382,3.64837398373984,0.240619847364738,0.277565414479797,"11313"
"WP382:MAPK signaling",0.0069204152249135,3.78113299906702,3.6336032388664,0.10478822904114,0.172958243136831,"2002, 4296"
"GO:0001934~positive regulation of protein phosphorylation",0.00598802395209581,3.70128992412694,3.61895161290323,0.242322666991482,0.279309761717168,"7422"
"R-HSA-9705671~SARS-CoV-2 activates/modulates innate and adaptive immune responses",0.00595238095238095,3.67130319510468,3.59,0.244021754838807,0.280826292882052,"6772"
"R-HSA-9007101~Rab regulation of trafficking",0.00595238095238095,3.67130319510468,3.59,0.244021754838807,0.280826292882052,"23163"
"GO:0010629~negative regulation of gene expression",0.00680272108843537,3.70467593041421,3.56150793650794,0.108339430603374,0.173841474078798,"1108, 7422"
"R-HSA-2559580~Oxidative Stress Induced Senescence",0.00591715976331361,3.64180380589726,3.56150793650794,0.245717118895234,0.282555399671521,"1019"
"GO:0009410~response to xenobiotic stimulus",0.00677966101694915,3.68975518129785,3.54743083003953,0.109053601192534,0.173872922577258,"1019, 6772"
"R-HSA-381426~Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)",0.00588235294117647,3.61278032181212,3.53346456692913,0.247408767132586,0.284277524587637,"51280"
"GO:0005525~GTP binding",0.00705882352941176,3.71019845428359,3.505859375,0.0538063022449041,0.130709414033877,"126298, 1915, 7283"
"R-HSA-6807070~PTEN Regulation",0.00584795321637427,3.5842215558549,3.505859375,0.249096707506027,0.285992693178942,"1108"
"R-HSA-196849~Metabolism of water-soluble vitamins and cofactors",0.00581395348837209,3.55534488453036,3.47868217054264,0.250780947954094,0.287251046718333,"31"
"WP4217:Ebola virus infection in host",0.00581395348837209,3.55534488453036,3.47868217054264,0.250780947954094,0.287251046718333,"6772"
"WP5095:Overview of proinflammatory and profibrotic mediators",0.00581395348837209,3.55534488453036,3.47868217054264,0.250780947954094,0.287251046718333,"7422"
"KW-0254~Endocytosis",0.00578034682080925,3.52769492722898,3.45192307692308,0.252461496398732,0.288499291906507,"598"
"KW-0339~Growth factor",0.00578034682080925,3.52769492722898,3.45192307692308,0.252461496398732,0.288499291906507,"7422"
"hsa04926_Relaxin_signaling_pathway",0.00578034682080925,3.52769492722898,3.45192307692308,0.252461496398732,0.288499291906507,"7422"
"GO:0071456~cellular response to hypoxia",0.00574712643678161,3.50047730935294,3.42557251908397,0.254138360745327,0.289737508554011,"7422"
"R-HSA-2132295~MHC class II antigen presentation",0.00574712643678161,3.50047730935294,3.42557251908397,0.254138360745327,0.289737508554011,"1075"
"WP236:Adipogenesis",0.00574712643678161,3.50047730935294,3.42557251908397,0.254138360745327,0.289737508554011,"6772"
"WP2059:Alzheimer 39 s disease and miRNA effects",0.00655737704918033,3.54615953475794,3.41254752851711,0.116264738969121,0.179292465883961,"51107, 5715"
"WP5124:Alzheimer 39 s disease",0.00655737704918033,3.54615953475794,3.41254752851711,0.116264738969121,0.179292465883961,"51107, 5715"
"R-HSA-76002~Platelet activation, signaling and aggregation",0.0065359477124183,3.53249092335359,3.39962121212121,0.11699260215534,0.18001838459138,"3309, 7422"
"WP3915:Angiopoietin like protein 8 regulatory pathway",0.00571428571428571,3.47368182283821,3.39962121212121,0.25581154888274,0.291191856342823,"4296"
"hsa03040_Spliceosome",0.00571428571428571,3.47368182283821,3.39962121212121,0.25581154888274,0.291191856342823,"7919"
"R-HSA-1280215~Cytokine Signaling in Immune system",0.0072202166064982,3.79461681027749,3.3953341740227,0.0079077374651508,0.0702207499359569,"2002, 3185, 3309, 598, 6772, 7422"
"GO:0001525~angiogenesis",0.00649350649350649,3.50546847387812,3.37406015037594,0.118451896941276,0.18113990503024,"7422, 80155"
"GO:0006397~mRNA processing",0.00645161290322581,3.47880176644903,3.34888059701493,0.119915892396387,0.181497561885037,"3185, 7919"
"GO:0000278~mitotic cell cycle",0.00564971751412429,3.42115287236,3.34888059701493,0.259146928003038,0.294530837489876,"7283"
"GO:0016477~cell migration",0.00638977635782748,3.43947682749809,3.31180811808118,0.122120550217246,0.182185953226339,"8079, 977"
"R-HSA-202733~Cell surface interactions at the vascular wall",0.00558659217877095,3.37012760170027,3.29963235294118,0.262467696541294,0.29761236488622,"50848"
"KW-0051~Antiviral defense",0.00558659217877095,3.37012760170027,3.29963235294118,0.262467696541294,0.29761236488622,"6772"
"WP5224:2q37 copy number variation syndrome",0.00558659217877095,3.37012760170027,3.29963235294118,0.262467696541294,0.29761236488622,"1915"
"WP2004:miR targeted genes in lymphocytes",0.00665188470066519,3.46826278092374,3.28353658536585,0.0629972313567249,0.138752116356119,"1075, 7170, 80155"
"R-HSA-3247509~Chromatin modifying enzymes",0.00632911392405063,3.40101869311735,3.27554744525547,0.124335402930959,0.183991278074601,"1019, 1108"
"R-HSA-4839726~Chromatin organization",0.00632911392405063,3.40101869311735,3.27554744525547,0.124335402930959,0.183991278074601,"1019, 1108"
"GO:0016887~ATP hydrolysis activity",0.00662251655629139,3.450946576389,3.26759708737864,0.0637330027444922,0.138752116356119,"1108, 3309, 7919"
"GO:0007155~cell adhesion",0.00675675675675676,3.49464705600979,3.2518115942029,0.0339915793998305,0.108255790914677,"50848, 780, 977, 9777"
"R-HSA-453279~Mitotic G1 phase and G1/S transition",0.00552486187845304,3.32059081069354,3.2518115942029,0.265773917016926,0.300895508832919,"1019"
"hsa04380_Osteoclast_differentiation",0.00552486187845304,3.32059081069354,3.2518115942029,0.265773917016926,0.300895508832919,"6772"
"R-HSA-9824446~Viral Infection Pathways",0.0069204152249135,3.6213351709322,3.24788902291918,0.00973234993501284,0.0703557202778735,"1108, 1915, 2002, 51114, 598, 6772"
"GO:0006468~protein phosphorylation",0.0062111801242236,3.32659069565798,3.20535714285714,0.128794792428772,0.189138413407198,"1019, 4296"
"WP5083:Neuroinflammation and glutamatergic signaling",0.00546448087431694,3.27247833051038,3.20535714285714,0.269065651688169,0.304152144848124,"6772"
"hsa05418_Fluid_shear_stress_and_atherosclerosis",0.00546448087431694,3.27247833051038,3.20535714285714,0.269065651688169,0.304152144848124,"7422"
"R-HSA-913531~Interferon Signaling",0.00619195046439629,3.31449704004836,3.19395017793594,0.129541775794453,0.189211068333872,"3309, 6772"
"R-HSA-9609690~HCMV Early Events",0.00543478260869565,3.2489371710297,3.18262411347518,0.27070610623169,0.305770582597861,"2002"
"GO:0045766~positive regulation of angiogenesis",0.00540540540540541,3.2257296838408,3.16021126760563,0.272342962553145,0.307145835365941,"7422"
"GO:0019221~cytokine-mediated signaling pathway",0.00540540540540541,3.2257296838408,3.16021126760563,0.272342962553145,0.307145835365941,"6772"
"R-HSA-72203~Processing of Capped Intron-Containing Pre-mRNA",0.00611620795107034,3.26697655558064,3.14912280701754,0.13254013024892,0.192630248824076,"3185, 7919"
"GO:0020037~heme binding",0.00537634408602151,3.20284884245681,3.13811188811189,0.273976228361831,0.308512816717972,"6391"
"hsa04936_Alcoholic_liver_disease",0.00537634408602151,3.20284884245681,3.13811188811189,0.273976228361831,0.308512816717972,"31"
"GO:0030336~negative regulation of cell migration",0.0053475935828877,3.18028781898383,3.11631944444444,0.275605911350918,0.309871573391477,"7170"
"GO:0007015~actin filament organization",0.0053475935828877,3.18028781898383,3.11631944444444,0.275605911350918,0.309871573391477,"7170"
"GO:0000226~microtubule cytoskeleton organization",0.00531914893617021,3.15803997689985,3.0948275862069,0.277232019197485,0.311460819113738,"7283"
"R-HSA-9842860~Regulation of endogenous retroelements",0.00529100529100529,3.13609886412541,3.0736301369863,0.278854559562551,0.31232563437243,"1108"
"KW-0090~Biological rhythms",0.00529100529100529,3.13609886412541,3.0736301369863,0.278854559562551,0.31232563437243,"4800"
"WP2857:Mesodermal commitment pathway",0.00529100529100529,3.13609886412541,3.0736301369863,0.278854559562551,0.31232563437243,"31"
"GO:0031267~small GTPase binding",0.00597014925373134,3.17585282490946,3.06313993174061,0.138585196172433,0.198355218114227,"23163, 4296"
"R-HSA-166016~Toll Like Receptor 4 (TLR4) Cascade",0.00526315789473684,3.11445820637789,3.05272108843537,0.280473540091112,0.313898958161557,"2002"
"hsa05224_Breast_cancer",0.00523560209424084,3.09311190080087,3.03209459459459,0.282088968412165,0.315465907422764,"1019"
"KW-0648~Protein biosynthesis",0.00520833333333333,3.0720540098598,3.01174496644295,0.283700852138748,0.317026505250394,"1915"
"GO:0042803~protein homodimerization activity",0.00636132315521628,3.27541556041402,3.00368139223561,0.024575152644872,0.0937567672519203,"4296, 50848, 6772, 7170, 7422"
"GO:0004672~protein kinase activity",0.00586510263929619,3.11073059636332,3.00167224080268,0.143159326846299,0.202636148627853,"4296, 780"
"R-HSA-9694516~SARS-CoV-2 Infection",0.00586510263929619,3.11073059636332,3.00167224080268,0.143159326846299,0.202636148627853,"51114, 6772"
"GO:0043524~negative regulation of neuron apoptotic process",0.00518134715025907,3.05127875549521,2.99166666666667,0.285309198867973,0.318338138874014,"598"
"R-HSA-69242~S Phase",0.00518134715025907,3.05127875549521,2.99166666666667,0.285309198867973,0.318338138874014,"1019"
"GO:0031647~regulation of protein stability",0.00515463917525773,3.03078606016482,2.97185430463576,0.286914016181053,0.319885109364721,"23163"
"R-HSA-9012999~RHO GTPase cycle",0.00606060606060606,3.12276695723667,2.96530837004405,0.0800982496916833,0.150293475182747,"4296, 7170, 7919"
"GO:0031625~ubiquitin protein ligase binding",0.00579710144927536,3.06876600232288,2.96204620462046,0.146227028023496,0.204329706984762,"3309, 4720"
"WP3932:Focal adhesion PI3K Akt mTOR signaling",0.00579710144927536,3.06876600232288,2.96204620462046,0.146227028023496,0.204329706984762,"31, 7422"
"GO:0072659~protein localization to plasma membrane",0.00510204081632653,2.99060815139417,2.93300653594771,0.290113092804351,0.322715019710231,"50848"
"KW-0508~mRNA splicing",0.00574712643678161,3.03801739848623,2.93300653594771,0.148537057404232,0.205813346384087,"3185, 7919"
"hsa04261_Adrenergic_signaling_in_cardiomyocytes",0.00510204081632653,2.99060815139417,2.93300653594771,0.290113092804351,0.322715019710231,"7170"
"GO:0008283~cell population proliferation",0.0050761421319797,2.97091341362148,2.91396103896104,0.291707367197808,0.323750979503628,"780"
"R-HSA-1169410~Antiviral mechanism by IFN-stimulated genes",0.0050761421319797,2.97091341362148,2.91396103896104,0.291707367197808,0.323750979503628,"6772"
"hsa04921_Oxytocin_signaling_pathway",0.0050761421319797,2.97091341362148,2.91396103896104,0.291707367197808,0.323750979503628,"2002"
"R-HSA-1643685~Disease",0.00637280934678704,3.6419325748592,2.90923824959481,0.00054348661299337,0.0398103944017643,"1019, 1108, 1915, 2002, 31, 4296, 51107, 51114, 57085, 598, 6772, 7170"
"GO:0007010~cytoskeleton organization",0.00505050505050505,2.95147463998024,2.89516129032258,0.293298142341664,0.324483207560646,"7170"
"GO:0042127~regulation of cell population proliferation",0.00505050505050505,2.95147463998024,2.89516129032258,0.293298142341664,0.324483207560646,"6772"
"WP4262:Breast cancer pathway",0.00505050505050505,2.95147463998024,2.89516129032258,0.293298142341664,0.324483207560646,"1019"
"hsa04934_Cushing_syndrome",0.00505050505050505,2.95147463998024,2.89516129032258,0.293298142341664,0.324483207560646,"1019"
"GO:0043065~positive regulation of apoptotic process",0.0056657223796034,2.98809730387397,2.88585209003215,0.152404137395937,0.208713588023686,"4296, 598"
"R-HSA-73887~Death Receptor Signaling",0.0050251256281407,2.93228685949381,2.87660256410256,0.294885425738141,0.325797246384899,"51107"
"R-HSA-9013148~CDC42 GTPase cycle",0.005,2.91334522786529,2.85828025477707,0.296469224873753,0.326807685808916,"4296"
"hsa04218_Cellular_senescence",0.005,2.91334522786529,2.85828025477707,0.296469224873753,0.326807685808916,"1019"
"KW-0436~Ligase",0.00497512437810945,2.8946450237094,2.84018987341772,0.298049547219351,0.327809749757018,"31"
"hsa04110_Cell_cycle",0.00497512437810945,2.8946450237094,2.84018987341772,0.298049547219351,0.327809749757018,"1019"
"GO:0007605~sensory perception of sound",0.00495049504950495,2.87618164490688,2.82232704402516,0.299626400230141,0.328557392467931,"26018"
"R-HSA-9612973~Autophagy",0.00495049504950495,2.87618164490688,2.82232704402516,0.299626400230141,0.328557392467931,"1915"
"hsa04217_Necroptosis",0.00495049504950495,2.87618164490688,2.82232704402516,0.299626400230141,0.328557392467931,"6772"
"R-HSA-1474165~Reproduction",0.00492610837438424,2.85795060507501,2.8046875,0.301199791345727,0.329789009208887,"1019"
"hsa04514_Cell_adhesion_molecules",0.00492610837438424,2.85795060507501,2.8046875,0.301199791345727,0.329789009208887,"50848"
"R-HSA-5633007~Regulation of TP53 Activity",0.00490196078431373,2.83994753014863,2.78726708074534,0.302769727990138,0.331260382005641,"1108"
"GO:0008083~growth factor activity",0.0048780487804878,2.82216815506687,2.77006172839506,0.304336217571859,0.332477672440547,"7422"
"R-HSA-199977~ER to Golgi Anterograde Transport",0.0048780487804878,2.82216815506687,2.77006172839506,0.304336217571859,0.332477672440547,"1075"
"hsa05206_MicroRNAs_in_cancer",0.00485436893203883,2.80460832056118,2.75306748466258,0.305899267483867,0.33393623462285,"7422"
"GO:0008284~positive regulation of cell population proliferation",0.00561797752808989,2.86845089908636,2.73073022312373,0.0967772782040004,0.168280548628217,"1019, 112939, 7422"
"R-HSA-9609646~HCMV Infection",0.00480769230769231,2.77013114657229,2.71969696969697,0.309015077793275,0.336835631671985,"2002"
"WP3929:Chemokine signaling",0.00480769230769231,2.77013114657229,2.71969696969697,0.309015077793275,0.336835631671985,"6772"
"R-HSA-109581~Apoptosis",0.00478468899521531,2.75313225527183,2.70331325301205,0.310567852899358,0.338276508920119,"598"
"hsa04140_Autophagy",0.004739336492891,2.71991132189087,2.67113095238095,0.313663179670552,0.341394174009925,"598"
"KW-0444~Lipid biosynthesis",0.00471698113207547,2.70359651267005,2.65532544378698,0.315205745952132,0.34281842451364,"31"
"KW-0072~Autophagy",0.00469483568075117,2.68747409308955,2.63970588235294,0.316744923883176,0.344236879442769,"8508"
"R-HSA-5663205~Infectious disease",0.0056550424128181,2.90052686484704,2.63196480938416,0.0250196163457821,0.0946443591636569,"1108, 1915, 2002, 51114, 598, 6772"
"hsa04141_Protein_processing_in_endoplasmic_reticulum",0.00467289719626168,2.67154063387935,2.62426900584795,0.318280720733707,0.345649559581082,"3309"
"R-HSA-168898~Toll-like Receptor Cascades",0.00465116279069767,2.65579278870834,2.60901162790698,0.31981314375852,0.346799597043843,"2002"
"KW-0788~Thiol protease",0.00465116279069767,2.65579278870834,2.60901162790698,0.31981314375852,0.346799597043843,"1075"
"GO:0044877~protein-containing complex binding",0.00516795865633075,2.68718289703767,2.60144927536232,0.179198721712469,0.232529785038766,"23163, 4697"
"R-HSA-162582~Signal Transduction",0.00566465256797583,3.39577752691871,2.57016036655212,0.000344938185431168,0.0364384403839562,"1019, 1108, 2002, 23163, 26018, 3185, 4296, 50848, 51107, 51114, 598, 6772, 7170, 7422, 7919"
"R-HSA-8978868~Fatty acid metabolism",0.00458715596330275,2.609630670456,2.56428571428571,0.324390242198862,0.351242945174673,"31"
"GO:0042802~identical protein binding",0.00556173526140156,3.0094295972185,2.54393424036281,0.00465530005198209,0.065587631845631,"1075, 31, 4296, 57085, 598, 6772, 7170, 7283, 7422, 7919"
"GO:0071222~cellular response to lipopolysaccharide",0.00452488687782805,2.56502610323906,2.52106741573034,0.328937235925065,0.355378355921991,"1019"
"GO:0008201~heparin binding",0.00452488687782805,2.56502610323906,2.52106741573034,0.328937235925065,0.355378355921991,"7422"
"KW-0012~Acyltransferase",0.00452488687782805,2.56502610323906,2.52106741573034,0.328937235925065,0.355378355921991,"51114"
"GO:0004252~serine-type endopeptidase activity",0.00448430493273543,2.5360492911116,2.49305555555556,0.331951935806175,0.358371102399445,"1075"
"R-HSA-3700989~Transcriptional Regulation by TP53",0.00497512437810945,2.57253462914513,2.49305555555556,0.191251449046794,0.242972699830695,"1108, 4697"
"R-HSA-422475~Axon guidance",0.00512820512820513,2.59120450190922,2.47472426470588,0.120542088903207,0.181497561885037,"11313, 51107, 8079"
"GO:0106310~protein serine kinase activity",0.00493827160493827,2.55091588985892,2.47245179063361,0.193676013187571,0.244810491216386,"1019, 4296"
"KW-0694~RNA-binding",0.00520156046814044,2.61717612828267,2.46227709190672,0.078334599837563,0.149320483901981,"11163, 23211, 3185, 7919"
"KW-0418~Kinase",0.00514800514800515,2.58762206174193,2.43554952510176,0.0808124025048771,0.150293475182747,"1019, 4296, 780, 9807"
"GO:0004674~protein serine/threonine kinase activity",0.00480769230769231,2.47418164743922,2.39973262032086,0.202601576892789,0.252176134365281,"1019, 4296"
"GO:0005524~ATP binding",0.00521852576647097,2.71774094734511,2.39812959251837,0.0163385965703676,0.0833400575386082,"1019, 1108, 31, 3309, 4296, 780, 7919, 9807"
"R-HSA-69275~G2/M Transition",0.00432900432900433,2.42671154421168,2.38696808510638,0.343878933228588,0.370700983943989,"7283"
"R-HSA-9675108~Nervous system development",0.00491803278688525,2.47341716643948,2.36599297012302,0.132922981746172,0.192995211355938,"11313, 51107, 8079"
"R-HSA-453274~Mitotic G2-G2/M phases",0.00429184549356223,2.40088904536125,2.36184210526316,0.346828014151294,0.373605177008563,"7283"
"GO:0045892~negative regulation of DNA-templated transcription",0.00490196078431373,2.46446844081996,2.3577057793345,0.133932707057638,0.193884798260315,"1108, 112939, 23211"
"GO:0010467~gene expression",0.00427350427350427,2.38781949478854,2.34947643979058,0.34829769287169,0.374912652503325,"2002"
"GO:0005125~cytokine activity",0.00425531914893617,2.37522766298677,2.33723958333333,0.349764139711909,0.376214731775292,"7422"
"GO:0060090~molecular adaptor activity",0.00423728813559322,2.36276109202899,2.32512953367876,0.351227361614056,0.376682346094137,"1915"
"R-HSA-948021~Transport to the Golgi and subsequent modification",0.00423728813559322,2.36276109202899,2.32512953367876,0.351227361614056,0.376682346094137,"1075"
"hsa04062_Chemokine_signaling_pathway",0.00423728813559322,2.36276109202899,2.32512953367876,0.351227361614056,0.376682346094137,"6772"
"GO:0006897~endocytosis",0.00420168067226891,2.33820004148832,2.30128205128205,0.354144158299792,0.379532693422967,"598"
"KW-0723~Serine/threonine-protein kinase",0.0046189376443418,2.36386492624985,2.29539641943734,0.216491172572365,0.261251703310144,"1019, 4296"
"R-HSA-73857~RNA Polymerase II Transcription",0.00494350282485876,2.52725797288358,2.27791878172589,0.03154070475787,0.104541023688415,"1019, 1108, 4697, 4800, 6772, 7422, 7919"
"KW-0507~mRNA processing",0.00458715596330275,2.34542353464968,2.27791878172589,0.218952593198388,0.262758387729423,"3185, 7919"
"GO:0070374~positive regulation of ERK1 and ERK2 cascade",0.004149377593361,2.30227129969875,2.26641414141414,0.358495339010007,0.383354504853766,"7422"
"R-HSA-2559583~Cellular Senescence",0.004149377593361,2.30227129969875,2.26641414141414,0.358495339010007,0.383354504853766,"1019"
"hsa05202_Transcriptional_misregulation_in_cancer",0.004149377593361,2.30227129969875,2.26641414141414,0.358495339010007,0.383354504853766,"598"
"GO:0003700~DNA-binding transcription factor activity",0.00471698113207547,2.36168850791359,2.26260504201681,0.146260123682767,0.204329706984762,"2002, 4800, 6772"
"R-HSA-5357801~Programmed Cell Death",0.00413223140495868,2.29053318163159,2.25502512562814,0.359939356254778,0.384617911679978,"598"
"hsa05207_Chemical_carcinogenesis",0.00411522633744856,2.27891174399265,2.24375,0.361380196750266,0.385876084722405,"7422"
"WP3594:Circadian rhythm genes",0.00409836065573771,2.2674055014047,2.23258706467662,0.362817867322943,0.387129042700737,"1019"
"R-HSA-196854~Metabolism of vitamins and cofactors",0.00408163265306122,2.25601294822442,2.22153465346535,0.364252374784967,0.388376804264903,"31"
"GO:0043410~positive regulation of MAPK cascade",0.0040650406504065,2.2447325675583,2.21059113300493,0.3656837259342,0.389336234370351,"7422"
"R-HSA-9705683~SARS-CoV-2-host interactions",0.0040650406504065,2.2447325675583,2.21059113300493,0.3656837259342,0.389336234370351,"6772"
"GO:0006412~translation",0.00403225806451613,2.22244057601571,2.1890243902439,0.368536986414466,0.39208909593115,"1915"
"GO:0003714~transcription corepressor activity",0.004,2.20084625712841,2.16787439613527,0.371377702861932,0.394252416444007,"1108"
"R-HSA-397014~Muscle contraction",0.004,2.20084625712841,2.16787439613527,0.371377702861932,0.394252416444007,"7170"
"R-HSA-5617833~Cilium Assembly",0.004,2.20084625712841,2.16787439613527,0.371377702861932,0.394252416444007,"7283"
"GO:0003723~RNA binding",0.0047074646940148,2.39362143100908,2.16637931034483,0.0398577738277823,0.114417259467818,"11163, 1915, 23211, 3185, 7919, 80155, 8125"
"R-HSA-1266738~Developmental Biology",0.00468854655056932,2.38292767393109,2.15745192307692,0.0406216071085298,0.115201873585355,"1019, 1108, 11313, 26018, 51107, 7374, 8079"
"R-HSA-68877~Mitotic Prometaphase",0.00398406374501992,2.19006962448495,2.15745192307692,0.372793373917008,0.395468713098057,"7283"
"R-HSA-212436~Generic Transcription Pathway",0.00463678516228748,2.33050821208652,2.1437101910828,0.058500198372364,0.133285832994577,"1019, 1108, 4697, 4800, 6772, 7422"
"R-HSA-109582~Hemostasis",0.00447093889716841,2.22584254369907,2.13690476190476,0.164888073013471,0.220000935304859,"3309, 50848, 7422"
"GO:0005516~calmodulin binding",0.00393700787401575,2.15839076080975,2.12677725118483,0.377021718918155,0.399664846754774,"1915"
"hsa04015_Rap1_signaling_pathway",0.00392156862745098,2.1480398657474,2.11674528301887,0.378424966812473,0.400862311193256,"7422"
"hsa05170_Human_immunodeficiency_virus_1_infection",0.00390625,2.13778961877684,2.10680751173709,0.379825125593011,0.40205477528451,"598"
"GO:0051015~actin filament binding",0.00387596899224806,2.11758316268702,2.08720930232558,0.382616202369105,0.404716777235191,"7170"
"GO:0006915~apoptotic process",0.00436046511627907,2.16512247562243,2.08075734157651,0.174189407175362,0.228049581333248,"1075, 598, 7422"
"GO:0019904~protein domain specific binding",0.00386100386100386,2.10762330360719,2.0775462962963,0.384007133608008,0.405894986100816,"3309"
"GO:0010468~regulation of gene expression",0.00383141762452107,2.08798198218222,2.05848623853211,0.386779814791691,0.408530950735275,"1019"
"R-HSA-8939211~ESR-mediated signaling",0.0037593984962406,2.04055249425235,2.01233183856502,0.393658266627213,0.415496657499184,"2002"
"KW-0378~Hydrolase",0.00435492651061513,2.21937107743778,1.99333703498057,0.0432987273255275,0.118004945397602,"1075, 1108, 11163, 11313, 1915, 3309, 7374, 7919"
"R-HSA-74160~Gene expression (Transcription)",0.00427089688834655,2.14750955116218,1.96083021223471,0.0622837326435795,0.138752116356119,"1019, 1108, 4697, 4800, 6772, 7422, 7919"
"GO:0043123~positive regulation of canonical NF-kappaB signal transduction",0.00366300366300366,1.97735886819676,1.95108695652174,0.403161573391807,0.42491489569712,"7422"
"hsa04820_Cytoskeleton_in_muscle_cells",0.00363636363636364,1.96004019685186,1.93426724137931,0.405849962551745,0.427440830437316,"7170"
"GO:0035556~intracellular signal transduction",0.00393700787401575,1.97414751479543,1.92596566523605,0.278537980774094,0.31232563437243,"11163, 8125"
"GO:0006511~ubiquitin-dependent protein catabolic process",0.0036101083032491,1.94301988940093,1.91773504273504,0.408526516180656,0.429950679744727,"5715"
"GO:0030154~cell differentiation",0.00401069518716578,1.97437748152207,1.90417256011315,0.208151719144584,0.255395534796327,"2002, 7422, 80155"
"GO:0051726~regulation of cell cycle",0.003584229390681,1.926290805719,1.90148305084746,0.411191285177472,0.432134313332136,"1019"
"hsa05171_Coronavirus_disease",0.003584229390681,1.926290805719,1.90148305084746,0.411191285177472,0.432134313332136,"6772"
"GO:0055085~transmembrane transport",0.00357142857142857,1.91803330975148,1.89345991561181,0.412519266286304,0.432781888520937,"598"
"GO:0050821~protein stabilization",0.00357142857142857,1.91803330975148,1.89345991561181,0.412519266286304,0.432781888520937,"80155"
"GO:0000122~negative regulation of transcription by RNA polymerase II",0.00403225806451613,1.97808007068682,1.88550420168067,0.160996504622966,0.215988900432825,"1108, 112939, 6772, 7422"
"R-HSA-8953854~Metabolism of RNA",0.00396825396825397,1.95137947570147,1.88286713286713,0.212796794557426,0.258789061607531,"3185, 7919, 8125"
"R-HSA-194315~Signaling by Rho GTPases",0.00396825396825397,1.95137947570147,1.88286713286713,0.212796794557426,0.258789061607531,"4296, 7170, 7919"
"GO:0045944~positive regulation of transcription by RNA polymerase II",0.00406173842404549,1.99956789882843,1.88234060402685,0.124217649504097,0.183991278074601,"2002, 3309, 4800, 6772, 7422"
"KW-0010~Activator",0.00395778364116095,1.94571102514887,1.87761506276151,0.21396185652722,0.2599122054829,"2002, 4800, 6772"
"GO:0006366~transcription by RNA polymerase II",0.00352112676056338,1.8856974696339,1.86203319502075,0.417801982002389,0.437825396018241,"4800"
"GO:0003682~chromatin binding",0.00380228136882129,1.8986787075263,1.85433884297521,0.293474573391028,0.324483207560646,"1108, 2002"
"R-HSA-9716542~Signaling by Rho GTPases, Miro GTPases and RHOBTB3",0.0038860103626943,1.90691107089791,1.84165526675787,0.22215788881685,0.264602688712752,"4296, 7170, 7919"
"R-HSA-6798695~Neutrophil degranulation",0.00377358490566038,1.88267369181094,1.83913934426229,0.296790392738444,0.326915733354752,"1075, 1915"
"GO:0019901~protein kinase binding",0.00375234521575985,1.87084377305433,1.82790224032587,0.299276120176727,0.328557392467931,"1915, 598"
"GO:0003729~mRNA binding",0.00346020761245675,1.84677932099402,1.82418699186992,0.424340127232569,0.444094672734419,"7919"
"hsa05131_Shigellosis",0.00343642611683849,1.83165939190561,1.80947580645161,0.426935245408178,0.446438354406124,"598"
"GO:0016192~vesicle-mediated transport",0.00340136054421769,1.80924039212453,1.78784860557769,0.43080649879436,0.450165136044036,"23163"
"WP5115:Network map of SARS CoV 2 signaling",0.00336700336700337,1.78756160049234,1.76673228346457,0.434652190936092,0.453536652223201,"6772"
"hsa04020_Calcium_signaling_pathway",0.00336700336700337,1.78756160049234,1.76673228346457,0.434652190936092,0.453536652223201,"7422"
"R-HSA-168256~Immune System",0.00376470588235294,1.88141423974274,1.71852561033988,0.0878420414613652,0.15832198939105,"1075, 1915, 2002, 3185, 3309, 598, 6772, 7422"
"R-HSA-1257604~PIP3 activates AKT signaling",0.00325732899022801,1.71874092364574,1.69981060606061,0.447288664928688,0.466058246173918,"1108"
"KW-0805~Transcription regulation",0.00372362432767894,1.87755364289116,1.69552896725441,0.0764105329959571,0.148660598723874,"1108, 112939, 1915, 2002, 23211, 4800, 6772, 80155, 8125"
"R-HSA-5668914~Diseases of metabolism",0.0032258064516129,1.69909426145733,1.68071161048689,0.451025483638533,0.469617863205722,"31"
"GO:0003676~nucleic acid binding",0.00320512820512821,1.68624065159939,1.6682156133829,0.453502967463173,0.471862107481214,"7919"
"R-HSA-168249~Innate Immune System",0.003584229390681,1.73771276508706,1.6682156133829,0.217015924578881,0.261669407002519,"1075, 1915, 2002, 598"
"GO:0001227~DNA-binding transcription repressor activity, RNA polymerase II-specific",0.00317460317460317,1.66731567360614,1.64981617647059,0.457198718434848,0.474696047134694,"112939"
"KW-0804~Transcription",0.00362173038229376,1.81815382630034,1.6484693877551,0.0878605988907328,0.15832198939105,"1108, 112939, 1915, 2002, 23211, 4800, 6772, 80155, 8125"
"GO:0006886~intracellular protein transport",0.00314465408805031,1.64880477558769,1.63181818181818,0.460870040717604,0.478168987005163,"23163"
"R-HSA-69278~Cell Cycle, Mitotic",0.00336134453781513,1.65493397566285,1.62296564195298,0.350275496608951,0.376488336413877,"1019, 7283"
"GO:0003713~transcription coactivator activity",0.00307692307692308,1.60714861009314,1.59131205673759,0.469342343136491,0.486270532316096,"5715"
"KW-0009~Actin-binding",0.00304878048780488,1.58992416631951,1.57456140350877,0.472933370123706,0.489299002281942,"7170"
"GO:0000978~RNA polymerase II cis-regulatory region sequence-specific DNA binding",0.00332778702163062,1.60123213083625,1.5447504302926,0.258757715360136,0.294316811337422,"112939, 2002, 4800, 6772"
"R-HSA-72766~Translation",0.00297619047619048,1.54572183224862,1.53156996587031,0.482393736184971,0.498734526119254,"1915"
"R-HSA-9006931~Signaling by Nuclear Receptors",0.00294117647058824,1.52451643736531,1.51094276094276,0.487061485080568,0.503205271962646,"2002"
"KW-0687~Ribonucleoprotein",0.00291545189504373,1.50898472477748,1.49583333333333,0.490535275716122,0.506080407693041,"3185"
"R-HSA-1852241~Organelle biogenesis and maintenance",0.00288184438040346,1.48876050087186,1.47615131578947,0.495131253013971,0.510462551488717,"7283"
"R-HSA-9006925~Intracellular signaling by second messengers",0.00286532951289398,1.47884674317483,1.46650326797386,0.497414022075852,0.512455374360846,"1108"
"GO:0005515~protein binding",0.003240058910162,Inf,1.4539764359352,6.88672378464446e-08,0.000100890503445041,"1019, 1075, 1108, 11163, 112939, 11313, 126298, 1915, 2002, 23163, 23211, 26018, 31, 3185, 3309, 4296, 4697, 4720, 4800, 50848, 51107, 51114, 51280, 57085, 5715, 598, 60685, 6391, 6772, 7170, 7283, 7374, 7422, 780, 7919, 80155, 8079, 8125, 84064, 8508, 9144, 977, 9777, 9807"
"GO:0000981~DNA-binding transcription factor activity, RNA polymerase II-specific",0.00313479623824451,1.49905231080803,1.45226537216828,0.295964808444088,0.326743364258168,"112939, 2002, 4800, 6772"
"R-HSA-1430728~Metabolism",0.00314889788573999,1.52128087181164,1.43698536139067,0.209203819455676,0.255760105742605,"11163, 31, 4697, 4720, 4800, 6391, 9807"
"WP2882:Nuclear receptors meta pathway",0.00280112044817927,1.44045963780765,1.42914012738854,0.506444652703491,0.521026275428802,"1019"
"R-HSA-446203~Asparagine N-linked glycosylation",0.00279329608938547,1.43579887568347,1.42460317460317,0.507562270699531,0.521443707275465,"1075"
"KW-0678~Repressor",0.00297176820208024,1.44380696313044,1.42234548335975,0.412693718951365,0.432781888520937,"112939, 8125"
"KW-0156~Chromatin regulator",0.00278551532033426,1.43116772232384,1.42009493670886,0.508677415325842,0.522223134865002,"1108"
"R-HSA-212165~Epigenetic regulation of gene expression",0.00273972602739726,1.40398702537353,1.39363354037267,0.515316640947483,0.52866868276475,"1108"
"R-HSA-199991~Membrane Trafficking",0.00290697674418605,1.40907416457955,1.38931888544892,0.424390813534598,0.444094672734419,"1075, 23163"
"GO:0003924~GTPase activity",0.00263852242744063,1.34436890505783,1.33556547619048,0.530469052235777,0.543452560507282,"1915"
"GO:0006357~regulation of transcription by RNA polymerase II",0.00290360046457607,1.37698766317914,1.33318478906714,0.320117354404341,0.346872725001745,"112939, 2002, 4800, 6772, 7422"
"GO:0043565~sequence-specific DNA binding",0.00263157894736842,1.34029883070699,1.33160237388724,0.531533473983504,0.544162501317843,"2002"
"GO:0003779~actin binding",0.00261096605744125,1.32823267869799,1.31985294117647,0.534712609754135,0.547034897548749,"7170"
"GO:0000977~RNA polymerase II transcription regulatory region sequence-specific DNA binding",0.00260416666666667,1.32425794573031,1.31598240469208,0.535767628830189,0.547731734986899,"6772"
"R-HSA-5653656~Vesicle-mediated transport",0.00274725274725275,1.32391140376992,1.30830903790087,0.455012366409481,0.472761075737511,"1075, 23163"
"R-HSA-1640170~Cell Cycle",0.00274725274725275,1.32391140376992,1.30830903790087,0.455012366409481,0.472761075737511,"1019, 7283"
"GO:0046872~metal ion binding",0.0027972027972028,1.33244182356044,1.27124645892351,0.288670113563781,0.321598263399954,"1108, 11163, 23211, 31, 4720, 6391, 780, 84064"
"R-HSA-392499~Metabolism of proteins",0.00275608635737253,1.30044615802327,1.25876577840112,0.340481795476223,0.367309153440844,"1075, 1915, 23163, 51107, 51280, 5715"
"KW-0234~DNA repair",0.0025,1.26369911163935,1.25700280112045,0.552333387192896,0.563880426646406,"7374"
"GO:0003677~DNA binding",0.00269905533063428,1.27000933637972,1.24479889042996,0.402225207081007,0.424233209772264,"1108, 4800, 60685, 6772"
"R-HSA-983169~Class I MHC mediated antigen processing & presentation",0.0024330900243309,1.22512798891784,1.21942934782609,0.563385756453715,0.574763323958699,"3309"
"WP5420:ADHD and autism ASD pathways",0.00241545893719807,1.21500663511284,1.20956873315364,0.56635346409233,0.577388883016885,"31"
"GO:0046982~protein heterodimerization activity",0.00239808153477218,1.20504809565526,1.19986631016043,0.569301455348307,0.579990703814513,"7170"
"KW-0443~Lipid metabolism",0.00252844500632111,1.2082472128833,1.19826435246996,0.501386479579198,0.516184956137403,"11313, 31"
"R-HSA-556833~Metabolism of lipids",0.00250312891113892,1.19494092037437,1.18560105680317,0.507101406772493,0.521335832225756,"31, 4800"
"R-HSA-597592~Post-translational protein modification",0.00256081946222791,1.19781315803074,1.17936925098555,0.443293280045511,0.462223953926459,"1075, 1915, 51280, 5715"
"GO:0051301~cell division",0.00232018561484919,1.16061639708028,1.15657216494845,0.582801791589893,0.593331914301038,"1019"
"R-HSA-1280218~Adaptive Immune System",0.0024330900243309,1.15820964133523,1.15064102564103,0.523304056111979,0.536487363333835,"1075, 3309"
"hsa01100_Metabolic_pathways",0.00249221183800623,1.16206534574502,1.14696485623003,0.465089134770541,0.482204941570307,"31, 4697, 4720, 6391"
"GO:0008285~negative regulation of cell population proliferation",0.00226757369614512,1.13079804967704,1.12751256281407,0.592190782052215,0.602471872018399,"780"
"GO:0006955~immune response",0.00225733634311512,1.12501373024509,1.121875,0.594043644421357,0.603937501094578,"1075"
"KW-0808~Transferase",0.00243190661478599,1.12712353698994,1.11241943480416,0.47200490356905,0.488683522069723,"1019, 4296, 51114, 780, 9807"
"KW-0221~Differentiation",0.00235571260306243,1.11776844129513,1.11214374225527,0.541884673431995,0.553599056190985,"7422, 80155"
"R-HSA-68886~M Phase",0.00220264317180617,1.09420802280586,1.09184914841849,0.604088266862073,0.613723516610913,"7283"
"KW-0813~Transport",0.00238777459407832,1.10384272356881,1.09184914841849,0.488970733160671,0.504821792868486,"23163, 4697, 4720, 6391, 7919"
"KW-0132~Cell division",0.00218340611353712,1.08340116930782,1.08132530120482,0.607680297952642,0.616945001039931,"1019"
"GO:0006954~inflammatory response",0.00214132762312634,1.05983449381739,1.05837264150943,0.615646315730957,0.624599620876629,"50848"
"KW-0227~DNA damage",0.00210526315789474,1.03978189955835,1.03877314814815,0.622594359736587,0.630775060175726,"7374"
"GO:0007399~nervous system development",0.00204918032786885,1.00864286462994,1.00842696629213,0.633623971557653,0.641505955999974,"7422"
"GO:0010628~positive regulation of gene expression",0.00204081632653061,1.00401502116992,1.00391498881432,0.635292633340098,0.642751179449754,"7422"
"GO:0006355~regulation of DNA-templated transcription",0.00206825232678387,0.968788512271819,0.97027027027027,0.617309404095732,0.625853478892904,"4800, 8079"
"GO:0001228~DNA-binding transcription activator activity, RNA polymerase II-specific",0.00186915887850467,0.909869998861654,0.912093495934959,0.670933640538728,0.678342155548127,"2002"
"GO:0007283~spermatogenesis",0.0018018018018018,0.87334992771774,0.87646484375,0.685659328191632,0.691322034274426,"598"
"KW-0238~DNA-binding",0.00191204588910134,0.861951787265684,0.874756335282651,0.68433025170835,0.690457175449541,"1108, 2002, 4800, 6772"
"KW-9996~Developmental protein",0.00186915887850467,0.866754020855073,0.873054474708171,0.675331435906922,0.681847383600029,"7422, 80155"
"KW-0217~Developmental protein",0.00186915887850467,0.866754020855073,0.873054474708171,0.675331435906922,0.681847383600029,"7422, 80155"
"KW-0645~Protease",0.00169491525423729,0.815877258826378,0.820383912248629,0.709894724454807,0.715265317280806,"1075"
"KW-0675~Receptor",0.00173210161662818,0.780808563782057,0.796126552335896,0.739172742545479,0.742721582873201,"50848, 57085, 780"
"GO:1990837~sequence-specific double-stranded DNA binding",0.00163934426229508,0.786226860174558,0.791446208112875,0.722913312309054,0.727881788682312,"2002"
"GO:0006508~proteolysis",0.00161290322580645,0.77217376029933,0.777729636048527,0.729206727725834,0.733714186894469,"1075"
"KW-0053~Apoptosis",0.00160513643659711,0.768052482759465,0.773706896551724,0.731067358956376,0.735081455642479,"598"
"KW-0560~Oxidoreductase",0.0015625,0.745482217641456,0.751675041876047,0.741377297664359,0.744426141931656,"4720"
"KW-0653~Protein transport",0.00146627565982405,0.694876743597995,0.70226917057903,0.76522112903195,0.767841749336854,"23163"
"GO:0007165~signal transduction",0.00149925037481259,0.679619658491168,0.694659442724458,0.792569344099416,0.793652829190461,"1019, 6772"
"GO:0006338~chromatin remodeling",0.00138312586445367,0.651514466354243,0.659926470588235,0.786419160851946,0.788572259170501,"1108"
"KW-0131~Cell cycle",0.00137741046831956,0.648546304150727,0.657027818448023,0.787894593697583,0.789511340469876,"1019"
"GO:0008270~zinc ion binding",0.00138121546961326,0.604256007750312,0.631745659314876,0.867748820681742,0.867748820681742,"1108, 23211, 60685"
"GO:0005509~calcium ion binding",0.00130039011703511,0.608701801433612,0.618112947658402,0.807979181463644,0.808531079811638,"3309"
